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11. Introduction
Contact allergy (delayed hypersensitivity) may develop as a result of skin exposure
to low molecular weight chemical substances (haptens) and can lead to allergic
contact dermatitis. To minimize or avoid exposure to contact allergens in the
environment, it is necessary to identify relevant allergens; thus knowledge about the
sensitizing potential of chemicals is essential. To be able to make valid risk
assessments, reliable predictive tests for contact allergy are of paramount
importance.
1.1 Contact allergy
1.1.1 Contact dermatitis
Allergic and irritant contact dermatitis (eczema) are common occupational skin
disorders, which are frequent causes of occupational illness. The most prevalent
locations of occupational contact dermatitis are on the hands, arms and face (1). A
combination of facts concerning occupational disorders reported to the Occupational
Injury Information System (ISA) in Sweden during 1990-1991 shows occupations
with an increased incidence of skin disorders (Figure 1) (2). However, contact
dermatitis can also be due to non-occupational exposure to allergens and irritants in
products (e.g. cosmetics, detergents, jewellery and skin care products) and is
frequently seen in the general population (1, 3).
642 3 51
Assistant nurse F
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Cook M
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Hairdresser F
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Figure 1. Occupations with an increased incidence of skin disorders, which were
reported to the Occupational Injury Information System (ISA) in Sweden during
1990-1991 (2). Number of cases from each occupation is shown in front of the
columns. F = female; M = male
2Irritant contact dermatitis is considered to be more prevalent than allergic contact
dermatitis (1). It is an unspecific inflammatory reaction in the skin, which is due to
irritating substances. It is often more pronounced if the skin barrier is compromised
due to frequent contact with water. The constitution of the skin in each individual is
also of importance and a person with dry skin, i.e. an atopic individual, has an
increased risk of developing irritant contact dermatitis (4-5). However, irritant
contact dermatitis leads to an impaired skin barrier function and may increase the
risk of developing an allergic contact dermatitis.
Allergic contact dermatitis is a specific inflammatory reaction due to sensitivity to
a chemical (contact allergen). Individuals differ in their susceptibility to contact
sensitization (6). Potent contact allergens may sensitize at the first exposure, while
moderate or weaker contact allergens need several exposures to sensitize. Some
contact allergens sensitize only after years of exposure. A contact allergy is
diagnosed by patch testing, where standard allergens (i.e. the standard series (1, 7))
and perhaps also products from the work and leisure environment are applied to the
skin of the patient’s back under occlusion for 48 h (1, 7). The test reactions are
examined after 72-96 h and the grade of reactivity is assessed according to
international recommendations (7). The 10 contact allergens that elicited most
positive reactions among occupationally exposed patients in Stockholm, Sweden
during 1993-1998 are presented in Table 1. These findings were in agreement with
those in a German multicenter study performed between 1990 and 1995 (10).
Table 1. Standard patch test results between 1993 and 1998 from the Department
of Occupational and Environmental Dermatology, Stockholm County Council,
Stockholm and data from sensitization experiments with guinea pigs.
_________________________________________________________________________
Allergen Humansa Guinea pigs
____________________________ ________________
Number of positive % positive n positive/n exposed
_________________________________________________________________________
Nickel sulfate 239 22.0 11/20b
Fragrance mix 91 8.1 -
Cobalt chloride, 0.5% pet. 84 7.6 43/50b
Potassium dichromate 77 6.9 10/10b
Colophony 61 5.5 13/20b
Balsam of Peru 49 4.4 positivec
Formaldehyde 36 3.2 17/19b
Thiuram mix 35 3.1 -
Kathon CG 28 2.5 7/20b
Germall II, 2% aq. 28 2.5 8/19b
_________________________________________________________________________
a)1100 patients were tested with each substance.
b)Experimental sensitization results from a list presented by Wahlberg and Boman in 1985 (8).
c)Experimental sensitization result from Klecak, 1985 (9).
- = no data available.
Millions of chemicals exist today and about 3700 of these have been described as
contact allergens (11-12). Every year thousands of new substances are synthesized
3and introduced on the market (12). If the components of a product show contact
allergenic potential there is a risk of sensitization in the exposed population. It is
therefore important to be able to use simple and reliable methods for predictive
testing of contact allergens in chemicals and products before they are introduced on
the market or when they are suspected as a cause of allergic contact dermatitis.
1.1.2 Contact allergen - antigen formation
The chemicals (contact allergens) suspected to give allergic contact dermatitis are
usually low molecular weight chemicals (haptens), MW below 700 (13-14). When
haptens come in contact with the skin they must first penetrate the skin barrier and
bind to skin constituents, i.e. soluble or cell-bound host proteins, to form a
complete non-self-antigen, which in turn can elicit an immune reaction (14). The
sensitizing capacity of contact allergens depends on their ability to form these
hapten-protein complexes. The sensitizer acts as an electrophile and the protein acts
as a nucleophile in most of these reactions, with the nucleophilic function in the side
groups (-NH2, -SH, -S-, -N-, -NH and -OH) of the amino acids. Some haptens
may instead easily form free radicals, which also bind to proteins in a free radical
mechanism. The bonds formed between contact allergens and proteins are mostly of
covalent nature, but metals form coordination bonds with proteins (15-16).
1.1.3 The skin - the Langerhans cell
The skin is the interface between man and his environment. The skin has two layers
- the outer epidermis, which is epithelial and firmly attached to the underlying
dermis of connective tissue. Beneath is the subcutis, i.e. loose connective tissue
which usually contains an abundance of fat. In the epidermis there are four different
cell types: keratinocytes, melanocytes, Merkel cells and the Langerhans cells. The
Langerhans cell is a dendritic cell and there are approximately 800 Langerhans cells
per square mm in human skin (17). Langerhans cells has also been studied in
guinea pigs and mice (18-19). They are the prime antigen-presenting cells in the
epidermis, and bear the important class-II major histocompatibility complex (MHC)
antigens, which are the ubiquitous keys that make the immune system start to react
when foreign substances penetrate the skin (17, 20). The Langerhans cells are the
first line of defence of the immune system in human skin as well as in that of guinea
pigs and mice.
1.1.4 Cells in the immune system
In the immune system, there are unspecific cells which react to all foreign materials
(antigens) giving an innate (non-adaptive) response, but there are also cells which
are activated by recognition of specific antigens, and which furthermore are able to
create a memory of these specific antigens, giving an adaptive response. These two
cell types are derived from a common stem cell, which differentiates into two main
lineages, one for the myeloid cells (unspecific cells) and one for the lymphoid cells
(specific cells). A dendritic cell lineage is also believed to develop from the stem
cell. In the myeloid lineage the myeloid progenitor differentiates into, e.g.,
macrophages, granulocytes and mast cells. The lymphoid progenitor in the
lymphoid lineage differentiates into, e.g., natural killer cells (NK-cells), B-cells
4(which produces antibodies) and T-cells (including memory cells). The dendritic
cell lineage includes the antigen presenting cells (APCs), e.g. Langerhans cells
(21).
1.1.5 Contact hypersensitivity
Allergic contact dermatitis is the clinical manifestation of a type-IV (delayed)
hypersensitivity reaction, which is a cell-mediated immunologic reaction. This
hypersensitivity is an unfavorable side effect of a well-functioning immune system.
The immune system defends us against infections and malignant cells, but in
allergic contact dermatitis it has reacted to environmental chemicals. The contact
allergic reaction has two phases: sensitization and elicitation (Figure 2). The
sensitization phase takes at least one week from exposure in experimental animals.
During sensitization the antigen (hapten-protein complex) is carried by Langerhans
cells to the paracortical area of the draining lymph nodes where the antigen is
presented to helper/inducer T cells (CD4+). About 5-7 days later specific memory T
cells (CD4+) have been developed and circulate in the body. At a future contact with
the hapten the memory T cells will recognize the antigen on the Langerhans cells
and become activated to release cytokines and induce a cascade of inflammatory
reactions. This is the elicitation phase. After 24-48 h, an inflammation has
developed (an eczema) in the skin at the site of exposure (14, 20).
Skin
Hapten
Langerhans 
cell
Local lymph node
T-cell
Activated 
specific T -cells
a b Inflammation
in the skin
Protein
Specific
T-memory cells Cytokines
Unspecific
inflammatory cells
Figure 2. Schematic illustration of a delayed hypersensitivity reaction. Sensitization
(a) and elicitation (b) in allergic contact dermatitis. a) The formed hapten-protein
complex (antigen) is carried by the Langerhans cells to the draining lymph nodes
where the antigen is presented to helper/inducer T cells, which results in development
of specific memory T-cells. b) At a future contact with the hapten the memory T-cells
will recognize this hapten-protein complex, which activates specific T-cells to
proliferate and produce cytokines. Unspecific inflammatory cells will also be attracted
to the site of exposure and an inflammation develops.
51.2 Predictive test methods
1.2.1 Human predictive test methods
Several predictive tests for the allergenic potential of chemicals have been in use for
many years, with humans and experimental animals as subjects. Human test
methods were mainly developed during the years 1944-1980 (Table 2). The
preferred methods are the modified Draize procedure of Marzulli and Maibach
developed in 1973-1974 (27) and the modified maximization technique of Kligman
and Epstein developed in 1975 (28). One disadvantage of these tests is that large
numbers of volunteers are needed if an experiment is to give reliable results.
Another is that it is ethically less justifiable to perform these test on humans than on
experimental animals due to the risk that the humans become sensitized for the rest
of their lives and may develop eczema to the tested chemicals after future exposures.
However, these tests do eliminate the need to extrapolate results from animals to
humans.
Table 2. Human predictive test methods for contact allergens in chronological order.
_______________________________________________________________________________
Test methods No. subj. Skin site No. Duration Rest Challenge References
patches of exposure (no. days)
_______________________________________________________________________________
Repeated insult 100 ¢ Arm, back 10 24h 10-14 Repeat 1944, (22)
100 ª patch Draize
Prophetic 200 Arm, back 1 24-96h 10-14 48h 1944, (23)
Schwartz,
Peck
Repeated insult 200 - 10-15 24h 14-21 48h 1953, (24)
Shelanski
Schwartz 200 Arm, thigh, 1 72h 7-10 72h 1960, (25)
back Schwartz
Maximization 25 Forearm 5 24h 10 48h 1966, (26)
Kligman
Modified Draize 200 Arm 10 48h 14 72h 1974, (27)
Marzulli,
Maibach
Modified 25 - 7 24h 10 48h 1975, (28)
Maximization Kligman,
Epstein
HRIPTa 80-120 - 9 24h-48h 14-17 24h 1980, (29)
Stotts
_______________________________________________________________________________
a)HRIPT = Human repeat insult patch test.
61.2.2 Animal predictive test methods
The guinea pig is considered the most suitable experimental animal in predictive
testing for contact allergy and it has been used for decades. However, the methods
are quite costly and time-consuming. In addition it is sometimes hard to discriminate
between allergic reactions and irritant reactions. Inspection and palpation are used
for scoring, and are considered subjective. About 20 guinea pig protocols (Table 3)
have been described and some have been compared and evaluated (36, 43-46). The
methods use one of three different administration procedures at induction -
intradermal, topical or both in combination - for sensitization. The results from
guinea pig tests correlate well with the sensitizing properties of chemicals in man (9,
33, 44-45, 47-48) and are generally accepted by regulatory authorities (49). In the
first international guidelines set forth in 1959 the Draize test was included (30) to
screen out potent sensitizers. Since then several predictive guinea pig test methods
have been developed.
Table 3. Predictive test methods for contact allergens in guinea pigs
in chronological order.
_________________________________________________________________
Method References
_________________________________________________________________
Draize test 1959, Draize (30)
Buehler test 1965, Buehler (31)
Ear flank test 1967, Stevens (32)
Guinea pig maximization test 1969, Magnusson and Kligman (33)
Split adjuvant technique 1972, Maguire and Chase (34)
Optimization test 1975, Maurer et al. (35)
Freund's complete adjuvant test 1977, Klecak et al. (36)
Open epicutaneous test 1977, Klecak et al. (36)
TINA test 1977, Ziegler (37)
Modified guinea pig maximization test 1981, Sato et al. (38)
Single injection adjuvant test 1981, Goodwin et al. (39)
Cumulative contact enhancement test 1982, Tsuchiya et al. (40)
Epicutaneous maximization test 1983, Guillot et al. (41)
Guinea pig allergy test 1985, Doussou and Sicard (42)
_________________________________________________________________
The Buehler test was developed in 1965 (31, 50-51); this test uses three short
topical exposures (6 h) of the test chemical in the shoulder region at sensitization of
the animals (induction), and patches are applied to elicit the sensitization (challenge
tests) on the flanks. Magnusson and Kligman published an extensive study in 1970
(33, 47) where they investigated variables in the standard procedure for
sensitization experiments in guinea pigs. They performed several different tests with
focus on the experimental animal, the influence of some pharmaceuticals, ambient
conditions, induction of hypersensitivity, potentiation of hypersensitivity by
adjuvant, and elicitation of hypersensitivity and in the end developed a guinea pig
maximization test (GPMT). The contact allergens were classified on a five grade
scale (47). The GPMT method includes both intradermal administration with the
addition of Freund's complete adjuvant (FCA) (52) and occlusive topical application
(48 h) of the test substance in the shoulder region at induction, and challenge tests
on the flanks (Figure 3a). In 1977 Klecak developed the Freund’s complete
adjuvant test (FCAT) (9, 36), which has three intradermal administrations of the test
7substance with FCA in the shoulder region at induction, and challenge tests on the
flanks (Figure 3b). Tsuchiya et al. developed in 1982 the cumulative contact
enhancement test (CCET) (40). The CCET method has four occlusive topical
applications (24 h) of the test substance and intradermal administration of FCA in
the shoulder region at induction, and challenge tests on the flanks (Figure 3c). The
most commonly used predictive guinea pig methods in our laboratory are the
GPMT, the CCET and the FCAT depending on which route of exposure is deemed
most suitable for a particular study.
Guinea Pig Maximization Test (GPMT) 
Day 22
Test on the flanks 
top.
0 7
Induction in the shoulder-region
i.d. +FCA top.
Freunds complete adjuvant test (FCAT)
i.d. +FCA i.d. +FCA i.d. +FCA
0 10Day 6 22
Test on the flanks
top.
Induction in the shoulder-region
a)
Cumulative Contact Enhancement Test (CCET) 
Induction in the shoulder-region Test on the flanks
top.top. top.top.
Day 0 7 9 222
b)
c)
top. +FCA
Fig 3. Time-schedules for three predictive guinea pig test methods a) The guinea pig
maximization test (GPMT), b) The Freund's complete adjuvant test (FCAT) and c)
The cumulative contact enhancement test (CCET). i.d. = intradermal; top. = topical
8Two predictive guinea pig test methods are recommended in the current OECD
guidelines (53). The GPMT with the use of FCA is the most extensively used
predictive guinea pig method in Europe, whereas the Buehler test (without FCA) is
the method of choice in the USA (45, 54). The use of FCA to enhance the non-
specific immune response to contact allergens is controversial. Some investigators
believe that the use of FCA in predictive test methods will lead to an overestimation
of the allergenic potential of the chemical tested and that false positive reactions
sometimes have been provoked due to induced hyper-irritability, referred as "angry
back" or "excited skin syndrome" (55-59). GPMT has been shown in comparative
studies to be more sensitive (43-45, 60) and to better correlate with results in human
subjects (44-45) than the Buehler test. There is, however, a report which tries to
explain the lower sensitivity of the Buehler test by variations of the test procedure
(54).
To further improve the power of animal predictive tests for contact allergens, a
multi-dose-response induction protocol for the GPMT has been developed (61-64).
It increases the amount of information on the sensitizing capacity of a test substance
that can be obtained from each experimental study. The protocol is combined with a
statistical computer program, i.e. a logistic regression analysis, which uses all
available test data in the analysis of the results (65). The program uses this logistic
regression analysis to present curves fitted to the test results from the animal
sensitization experiments and calculates significance of the dose-response
relationship, the threshold concentration at sensitization and the estimated
concentration sensitizing 50% of the animals (EC50).
Table 4. Predictive test methods for contact allergens in mice
in chronological order.
_________________________________________________________________
Method References
_________________________________________________________________
Popliteal lymph node assay (PLNA) 1981, Gleichmann (66)
‘VVA mouse’ assay 1986, Maisey et al. (67)
Mouse ear swelling test (MEST) 1986, Gad et al. (68)
Local lymph node assay (LLNA)   in vitro   1986, Kimber et al. (69)
Mouse ear sensitization assay 1988, Descotes (70)
Local lymph node assay (LLNA)   in situ   1989, Kimber et al. (71)
Mouse ear swelling assay (MESA) 1991, Thorne et al. (72-73)
Sensitive mouse lymph node assay (SLNA) 1993, Ikarashi et al. (74)
Modified - Mouse ear swelling test (MEST) 1994, Gad (75)
_________________________________________________________________
In recent years predictive test methods in mice have also become available (Table
4). Two predictive mouse tests, the murine local lymph node assay (LLNA) and the
mouse ear swelling test (MEST), are recommended in the current OECD guidelines
(53). The mouse was originally introduced for investigations of delayed contact
sensitivity by Asherson and Ptak in 1968 and they used a mouse assay with MEST-
like methodology (76). In 1986, Gad et al. were the first to standardize the MEST
to be used for prediction of the skin sensitizing potential of environmental chemicals
(68) by performing investigations of several parameters before a final test design
9was established. The method includes intradermal administrations of FCA, tape
stripping, and has four topical applications of test substance on the abdomen at
induction. It has a challenge test on the ears, which measures the elicitation reaction
as degree of edema (Figure 4a). In addition to the protocol recommended (68), there
are other protocols using MEST methodology, which have been used in various
studies (paper IV, 77). Variations in the protocols using MEST methodology have
been described in several papers: variations include such as the site and number of
applications for the induction procedure, different enhancement techniques, and the
timing of challenge. Some variations in the protocols have recently been reviewed
(paper IV, 78). Some modifications have led to development of new test methods
(70, 72-73). The alterations are probably introduced as a result of the difficulty of
classifying moderate or weak contact allergen as sensitizer using the recommended
MEST protocol (79). Maisey and Miller used in 1986 the ‘VAA mouse’ assay (67,
80), which is similar to the recommended MEST protocol (68). Their protocol
included a prolonged induction regime with six topical treatments and vitamin A
acetate (VAA) supplemented diet and it was later referred to as the vitamin A
enhanced ear swelling assay (VAESA) (81). It was demonstrated that VAA
supplemented diet could increase the sensitivity of mouse assays using MEST
methodology (67, 82). Several investigators have thereafter included VAA
supplemented diet in their protocols (72-73, 83-84). A modification of the MEST
protocol was done by Gad in 1994, where vitamin A acetate supplemented diet also
was introduced (Figure 4b) (75, 85).
Kimber et al. developed the LLNA in 1986 (69). The method has three topical
applications on the ears at induction, but no challenge test (Figure 4c). The method
was first performed in vitro (69, 86), but was later modified to be carried out in situ
(71, 87). It estimates the proliferative activity in the local lymph nodes by
[3H]thymidine incorporation, which is stated to correlate with the severity of the
elicitation reaction induced by the test substance (88). The sensitivity of the method
has later been enhanced through a few modifications (89-90). Some have tried to
use different induction procedures in the hope of enhancing the sensitivity of the
method (74, 77, 91-94) and one modification has led to the development of a new
test method (74). Several studies in the last years have presented endpoints other
then [3H]thymidine incorporation to assess the sensitizing potential, e.g. use of an
isotope with a shorter half-life (95), counting cells by a microscopic observation
(93, 96-98), counting the proliferating cell nuclear antigen or a phenotypic
detemination of subpopulations of cells by a flow-cytometric analysis (97-107) or
detecting various cytokines by using an enzyme-linked immunosorbent assay
(ELISA) or a reverse transcriptase-polymerase chain reaction (RT-PCR) (96-98,
100, 106-112). In some studies, alternative species have been used in the local
lymph node assay, e.g. hamsters (113), guinea pigs (114-115) and rats (115-117).
Some recent papers describe the use of more than one test method for the prediction
of the sensitizing potential (98, 110, 118-121). A ‘new’ integrated model has also
been proposed, which includes measurements of ear edema and flow cytometric
analysis of the cells from the auricular lymph nodes whereafter the results are
assessed by using a differentiation index (122). There has been a proposal for a
10
scheme for the ranking of the sensitizing potential of a substance based on data from
several animal test methods (123).
a) Mouse ear swelling test (MEST) 
Day
Measurements
of ear thickness
Tape stripping and 
induction  on the 
abdomen
Challenge
on left ear
0 1 3 1210 11
24 h 48 h
2
top. + FCA top. top.top.
b) Mouse ear swelling test (MEST) 
Day
-14
Measurements
of ear thickness
Tape stripping and 
induction  on the 
abdomen Challenge
on left ear
0 1 3 1210 11
24 h 48 hVitamin A acetate 
supplemented diet
5
top. + FCA top. top. top.
Measurement of 
3H-thymidine
incorporation
c) Local Lymph Node Assay (LLNA)
Induction on
the ears
top. top. top.
Injection of 
3H-thymidine
in the tail vein
Cell suspension 
of lymphocytes
0 1 2 5 6Day
Figure 4. Time-schedule for predictive mouse test methods. a) The mouse ear
swelling test (MEST). b) A modified version of the mouse ear swelling test (MEST).
c) The local lymph node assay (LLNA). top. = topical
1.2.3 OECD-guidelines
The OECD Guideline for Testing of Chemicals 406 gives recommendations
concerning skin sensitization and was last updated in 1992 (53). It recommends two
predictive guinea pig tests -the guinea pig maximization test (GPMT) (8, 33, 47)
and the Buehler test (31, 50-51), and two predictive mouse tests - the murine local
lymph node assay (LLNA) (71, 87, 90) and the mouse ear swelling test (MEST)
(68, 75, 85). The mouse models are currently suggested for preliminary screening
of chemicals; in the case of a positive result the chemical may be classified as a
11
potential sensitizer, whereas if a negative result is obtained, a guinea pig test is
recommended.
1.2.4 Update of prospective in vitro predictive test methods and
some alternatives
Great effort is being made to reduce the use of experimental animals by refining and
in the end replacing the experimental animal predictive test methods (124), and the
development of in vitro test methods is currently in progress. Monolayer cultures in
media (125-129) and three dimensional skin equivalents with an air-liquid interface
(SKIN and EpiDerm) (130) have been developed and evaluated as potential in vitro
systems to predict the contact sensitization potential of chemicals. However, the
evaluated in vitro systems need further improvement (130) and at the moment no
reliable predictive in vitro test method is available.
Quantitative structure-activity relationship (QSAR) studies (131-136) is a new
approach to predicting the potential of contact allergens. However, only limited data
are available concerning some groups of chemicals and there is probably no general
QSAR that is valid for all chemicals. DEREK (Deductive Estimation of Risk from
Existing Knowledge) is one expert system (computer program), which predicts
potential skin sensitizers by identification of structural alerts (137). However, the
risk of inducing contact allergy is related not only to the inherent allergenic potential
(sensitization capacity) of a chemical. An important factor is penetration into the
skin, which depends on the physico-chemical properties of the substance,
concentration, skin barrier function and time of exposure (8). At present there is no
available alternative predictive test method, which could replace the predictive
animal test methods.
1.3 Risk assessment
Risk assessment is a procedure to define the adverse health effects resulting from
the exposure of individuals or populations to hazardous chemicals. It comprises
hazard identification, dose-response assessment, exposure assessment and risk
characterization (estimation) (138-139). The European Union (EU) has developed
criteria for classification of skin sensitizers on the basis of the properties of the
chemicals. The basis for classification includes: 1) practical experience showing the
substance or preparation to be capable of inducing sensitization by skin contact in a
substantial number of persons 2) or positive results from an appropriate animal test.
Compounds inducing at least 30% positive animals in an adjuvant test or 15% in a
non-adjuvant test are classified as skin sensitizers. If a substance is classified as
skin sensitizing the associated phrase R43 (‘May cause sensitization by skin
contact’) must appear on the label of its package (140).
There is a Nordic proposal for a classification system for chemical allergens (141)
causing skin allergy. All available data should be individually validated in
accordance with the classification of carcinogens adopted by the International
Agency for Research on Cancer (IARC) and the aggregate sum of knowledge
regarding the substances should be used for classification. This system has five
classification groups:
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I -the substance causes allergic contact dermatitis in humans to a significant degree,
IIA - the substance probably causes allergic contact dermatitis in humans to a
significant degree,
IIB - the substance possibly causes allergic contact dermatitis in humans to a
significant degree,
III - the available data do not permit classification of the substance, and
IV - the substance is not a significant contact allergen and cannot cause allergic
contact dermatitis in a significant number of persons.
Significant contact allergens are those classified in groups I, IIA and IIB (1, 141).
According to a 1996 report from a WHO Working Group, concerning criteria for
classification of skin sensitizing substances in the working and general
environments, substances may be classified into four different classes (139):
I - significant contact allergen,
II - probably a significant contact allergen,
III - not classifiable, and
IV - not a significant contact allergen.
13
2. Aims of the thesis
The purpose of this thesis is to evaluate some predictive test methods for contact
allergens. It is done to provide information such that the test methods giving the
clinically most relevant results should be used in risk assessment of chemical
products and in research.
The specific aims of the present study are:
• To evaluate the LLNA, a predictive test for contact allergens in mice.
• To evaluate a slightly modified version of a multi-dose-response induction
protocol applied on three predictive guinea pig tests for contact allergens: the
GPMT, the CCET and the FCAT.
• To evaluate the application of an adjusted multi-dose-response induction protocol
on a predictive test in mice, i.e. a modified MEST, for contact allergens.
• To compare the sensitizing potential of a preservative by using three predictive
guinea pig tests for contact allergens - the GPMT, the CCET using a slightly
modified multi-dose-response induction protocol, and the LLNA - and also to
make comparisons with patch test results in dermatitis patients.
• To compare the estimates of the sensitizing potential of the substances obtained
with the various predictive tests, to relate these estimates to human data from the
literature, and thereafter compare the predictive test methods used.
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3. Materials and methods
3.1 Animals
The experiments were carried out on outbred female Dunkin Hartley guinea pigs
(average weight 300-350g) (AB Sahlins Försöksdjursfarm, Malmö, Sweden) [III,
V], inbred female CBA/Ca strain mice (7-10 weeks) (B&K Universal AB,
Sollentuna, Sweden) [I-II, V], and inbred female Balb/c strain mice (3-4 weeks)
(B&K Universal AB, Sollentuna, Sweden and Charles River Sverige AB, Uppsala,
Sweden) [IV]. The guinea pigs were housed in groups of three [III, V] and the mice
in groups of four [I-II, V] or eight [IV] in Macrolon® cages on hardwood chip
bedding under controlled environmental conditions. Pelleted standard diet (B&K
Universal AB, Sollentuna, Sweden) [I-II, V] or pelleted standard diet (B&K
Universal AB, Sollentuna, Sweden) supplemented with 280 IU/g of vitamin A
acetate (AnalyCen Nordic AB, Lidköping, Sweden) [IV] were given to the mice and
SDS pellets (AB Sahlins Försöksdjursfarm, Malmö, Sweden) [III, V] was given to
the guinea pigs. Pellets and water were ad libitum. The guinea pigs were allowed to
acclimatize for at least 7 days and the mice for 5 days prior to first exposure. The
hair of the guinea pigs was removed with an electric clipper and shaver at induction
and challenge exposure sites. The guinea pigs were numbered individually and
randomly distributed to the cages. The mice [IV] were marked with Indian ink
individually.
The studies were approved by the local ethical committee.
3.2 Chemicals
The allergens used were: Ethyl-para-aminobenzoate (benzocaine), trans-cinnamic
aldehyde, 2,4-dinitrochlorobenzene (DNCB) and 2,4-dinitrofluorobenzene (DNFB)
[I]; Euxyl K 400 [V]; hydroxycitronellal (HC) [I and III-IV]; 2-
mercaptobenzothiazole [I]; methyldibromo glutaronitrile (MDBGN) (1,2-dibromo-
2,4-dicyanobutane) [IV-V]; 4-ethoxy-methylene-2-phenyl-2-oxazolin-5-one
(oxazolone) [I, IV]; para-phenylenediamine (p-PDA) [I] and potassium dichromate
(K2Cr2O7) [III-IV].
The irritants used were: Chloroform/methanol [I]; 2-hydroxybenzoic acid methyl
ester (methyl salicylate) [I-II]; nonanoic acid [II]; oxalic acid [I, IV]; sodium
dodecyl sulphate (SDS) and Triton X-100 [I].
The vehicles used were: Acetone:olive oil (4:1) (AOO) [I, IV]; arachis oil (AO)
[III, V]; acetone:arachis oil (1:2) (Ac:AO2) [V]; acetone:arachis oil (4:1) (AAO)
[IV]; dimethylformamide (DMF) [I-II, IV-V]; dimethylsulfoxide (DMSO) [IV];
methyl ethyl ketone (MEK) [I-II]; olive oil (OO) [III, V]; phenoxyethanol (PE) [V]
and physiological saline [III].
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3.3 Predictive test methods using mice [I-II, IV-V]
3.3.1 Local lymph node assay (LLNA) [I-II, V]
3.3.1.1 The assay
The LLNA (Figure 5) was carried out in studies I-II, V as recommended (90). Mice
in groups of four were treated with three topical applications of 25 m l of test
substance at one of three different concentrations (Tables I-II, paper I and Table I-
II, paper II) on the dorsum of both ears (days 0, 1 and 2). Control mice (n=4) were
treated in the same way with the vehicle alone or were untreated. At day 5, all mice
were injected intravenously through the tail vein with 20 m Ci [3H]thymidine in 250
m l of phosphate-buffered saline (PBS). After 5 h the mice were sacrificed and the
draining auricular lymph nodes were excised, pooled for each group and the
average lymph node weight was determined. A single-cell suspension of lymph
node cells was prepared, washed, precipitated and the incorporated [3H]thymidine
was determined by b -scintillation counting.
Test substance in vehicle was topically applied on the 
dorsum of both ears for three consecutive days.
Control mice were vehicle treated (or untreated).
5 days after the first treatment all mice were 
injected intravenously in the tail vein with
PBS containing 3H-thymidine .
5 hours later the draining auricular 
lymph nodes were excised and pooled 
for each group.
Lymph nodes
Single-cell suspension
Thymidine incorporation was measured with  ß-scintillation counting.
The local lymph node assay (LLNA)
Figure 5. The protocol for the local lymph node assay (LLNA) (90).
3.3.1.2 Calculation of results and the criteria for classification
Results were expressed as mean disintegrations per minute/lymph node (dpm/node)
for each experimental group. A stimulation index (SI), i.e. test group value/control
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group value, was calculated for each concentration of each substance tested.
According to the method (90), a chemical is classified as a sensitizer if two criteria
are fulfilled: 1) at least one concentration of the test chemical must induce a SI of a
threefold or greater value than that of the vehicle control; and 2) the results must not
be incompatible with a biological dose-response. The relative potency may be
ranked as a function of the concentration required to induce a stimulation index of 3,
and this concentration is expressed as an EC3 value (estimated concentration for
SI=3) (142-143).
3.3.2 A modified mouse ear swelling test (MEST) using a multi-
dose-response induction protocol [IV]
3.3.2.1 Irritancy threshold studies and calculation of the relative increase of ear
thickness
The mice were given VAA supplemented diet prior to pretest and maintained on it
thereafter. Each test substance or the vehicle alone was topically applied on the
dorsum of both ears on ten mice. Ear thickness measurements were performed on
all ears using a spring-loaded micrometer (Oditest, H C Kröplin, GMBH,
Schlüchtern, FRG). The measurements were carried out just prior to application of
the test substance (day 0) and were repeated 24 h (day 1) and 48 h (day 2) after
application of test substance. The relative increase in ear thickness in percent for
each ear was calculated using the following formula:
Relative increase in ear thickness in % =     B – A    x 100
A
In this equation, B = the mean ear thickness at post-challenge (24 h or 48 h) and
A = the mean ear thickness prior to challenge (0 h). Based on these calculations, the
concentration that gave a mild irritation and the highest non-irritating concentration
(< 10 % increase in ear thickness) were chosen as the highest concentration for
induction and for challenge, respectively.
The modified mouse ear swelling test (MEST) 
Day
-21
Measurements
of ear thickness
Induction
on the back
top. top. top.
Challenge
on the ears
0 2 4 9 10 11
24 h 48 hVitamin A acetate 
supplemented diet
0 h
Figure 6. Time-schedule for the modified mouse ear swelling test (MEST).
top. = topical
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3.3.2.2 The modified mouse ear swelling test (MEST)
In paper IV the MEST was performed essentially as described originally (68), but
with some modifications (Figures 6-7): The mice were given VAA supplemented
diet prior to test and maintained on it thereafter. A multi-dose-response induction
protocol (62) was followed. The mice were divided into five groups with eight
animals in each. One of the four concentrations of each test substance, or the
vehicle alone (the control group) was applied in each respective group (Table 9).
The induction was carried out by a total of three topical applications of 100 m l of test
substance in vehicle or the vehicle alone every second day (days 0, 2, 4) on the
clipped and shaven back of the mice (application site: 2x3 cm). After five days (day
9), the mice were challenged topically with 25 m l of the chosen concentration of test
substance in vehicle on the dorsum of both ears. Ear thickness measurements were
performed on days 9 to11 as described in section 3.3.2.1. The highest relative
increase in ear thickness in percent on either ear of each mouse was used for further
analysis.
The modified mouse ear swelling test (MEST)
Induction
Treatment with
test material in vehicle
Exposed
animals
Control
animals
Topical test
day 9
Topical exposure of test 
material in vehicle
Challenge
Topical applications 
days 0, 2, 4
Ear measurements
day 9, 10, 11
Ear thickness measurements 
in triplicate on each ear
Ear thickness measurements 
in triplicate on each earTreatment with vehicle
Topical exposure of test 
material in vehicle
Figure 7. The protocol for the modified ear swelling test (MEST), which is a
modification of the original MEST protocol (68).
3.3.2.3 Interpretation of results
To interpret the calculated relative increase in ear thickness, by performing statistical
dose-response analysis, several hypothetical ‘positive’ sensitization response
criteria (here called: sensitization criteria) were set, whereas Gad et al. (68) defined
a ‘positive’ response as a 20 % relative increase in ear thickness. Hypothetical
sensitization of each mouse was judged individually and to be classed as sensitized,
at least one ear of each mouse should have a relative increase in ear thickness of at
least 5 %, 10 %, 15 % or 20 % depending on the different sensitization criteria
used. The number of sensitized mice was counted at each sensitization criterion.
This gave lower sensitization rates in the induction groups when a higher
sensitization criterion is used. The relative number of sensitized mice in each
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induction group, giving series of sensitization rates at each sensitization criterion for
a test substance, was statistically analyzed (62, 65) (section 3.5.2). When no
significant dose-response relationship was obtained for a test substance, the
sensitization rates of the mice in the different induction groups were given at the
sensitization criterion of 10%, as this was chosen in the pretest to be the non-irritant
concentration for the test substances and the vehicles. The sensitizing capacity of a
test substance was assessed by calculating some parameters using the statistical
analysis program (62, 65). To be able to compare the sensitivity of this modified
MEST with the original protocol (68), the relative ear thickness in percent (termed
percent ear swelling in the original protocol (68)) from a test substance was
calculated for the different induction groups by using the following formula:
Relative ear thickness in % =     D x 100
C
In this equation, D = the sum of the mean ear thickness from all ear measurements
(all B) in an induction group at post-challenge (24 h or 48 h) and C = the sum of the
mean ear thickness from all ear measurements (all A) prior to challenge (0 h).
3.4 Predictive test methods using guinea pigs [III, V]
3.4.1 General procedure for the guinea pig test methods [III, V]
3.4.1.1 Irritancy threshold studies
In pre-tests the test substances were applied topically on the flanks for 24 h using
closed patch test on 3-6 animals and injected (intradermally) on 3-6 animals. The
concentration that gave minimal irritation and the highest non-irritating concentration
were selected to be used as the highest concentration for topical induction and for
challenge, respectively. The highest tolerable concentration for intradermal
induction was selected on the basis of the pre-test or on previous experience.
3.4.1.2 Induction
The induction was performed in paper V according to the methodology description
presented in section 3.4.3. The concentrations of the substance used are presented
in Table 12 [V].
3.4.1.3 Challenge and re-challenge
On day 22, patch testing was performed on the flanks for 24 h using Aluminium
Finn Chambers 8 mm Ø (Epitest Ltd Oy, Tussula, Finland) on Scanpor® tape
(Norgesplaster AS, Norway) and acrylastic bandage (Beiersdorf, FRG). Usually,
seven different challenge concentrations were used, in addition to one vehicle
control. The concentrations were randomly distributed to avoid bias from
differences in anatomical location. Test reactions were read blindly at 48 h and 72 h
after application. The minimum criterion for a positive reaction was a confluent
erythema (++) (144). The concentrations used at challenge and re-challenge are
summarized in Table 5 [III], Table 12 in the result section [V] and Table 2 in paper
V.
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Table 5. Concentration ranges for allergens used at induction and challenge.
_______________________________________________________________________________
Series Animal Allergen Method Induction conc. (%) Challenge conc.
group __________________________ (% ) top.
id top.
_______________________________________________________________________________
I 1 - 6 K2Cr2O7 GPMT 0.003 - 0.3 0.01; 1 0.01 - 0.1
II 7 - 12 K2Cr2O7 GPMT 0.0003 - 0.03 0.01; 1 0.01 - 0.1
III 13 - 18 K2Cr2O7 CCET - 0.01 - 1 0.0003 - 0.3
IV 19 - 24 K2Cr2O7 CCET - 0.0003 - 0.03 0.003 - 0.3
V 25 - 30 K2Cr2O7 FCAT 0.0001 - 0.01 - 0.0003 - 0.3
VI 31 - 36 HC GPMT 0.03 - 3 1; 100 0.01 - 10
VII 37 - 42 HC CCET - 1 - 100 0.01 - 10
VIII 43 - 48 HC FCAT 0.03 - 3 - 0.01 - 10
_______________________________________________________________________________
Concentrations in % (w/w) were increased by a factor of 3 giving a dose range of 10, 100 or 1000.
Potassium dichromate (K2Cr2O7) in saline at induction and challenge. Hydroxycitronellal (HC) in
arachis oil at induction and in olive oil at challenge. Intradermal concentrations (id) and topical
concentrations (top.)
GPMT = Guinea pig maximization test. CCET = Cumulative contact enhancement test. FCAT =
Freund's complete adjuvant test.
3.4.2 Specific procedures for the guinea pig test methods using a
multi-dose-response induction protocol [III, V]
3.4.2.1 Induction
A modification of the multi-dose-response induction protocol (62) was used in
paper III and V. In each of the experiments the animals were divided into 6 groups
(generally with 8 animals in each) with 5 induction concentrations and one sham
treated control group. The topical exposure in the GPMT was applied at two
concentrations – one higher and one lower – alternating between the experimental
groups in each series, starting with the lower topical concentration in the group with
the highest intradermal concentration applied (62). The concentrations used, are
summarized in Table 5 [III], Figure 17 in the result section [V] and Table 2 in paper
V. The inductions were done according to the three methods as described in 3.4.3-
3.4.5.
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3.4.3 Guinea pig maximization test (GPMT) [III, V]
The GPMT method (Figure 8) was carried out in accordance with the original
protocol (8, 33, 47) [V] and as discussed in section 3.4.1, or with the modifications
mentioned in section 3.4.2 [III]. The first exposure at induction (day 0) was made
by three pairs of intradermal injections of 0.1 ml in the shoulder region on each
animal; emulsion of FCA/vehicle (or FCA/water) (1:1), test substance in vehicle and
test substance in emulsion of FCA/vehicle (or FCA/water) (1:1). One week later
(day 7) a second exposure of 0.2 ml of test substance in the vehicle was applied
topically to the same area (each application: 2x4 cm) for 24 h using an occlusive
dressing with filter paper (Whatman, England) on Blenderm® tape (3M) and
acrylastic bandage. Challenge was performed as described in section 3.4.1.3.
Guinea Pig Maximization Test (GPMT)
Induction
Exposed
animals
Control
animals
Challenge
Closed patch testing
day 22
Intradermal 
injection x3 day  0
Topical exposure of
test material for 24h.
Topical exposure of 
test material for 24h.
• FCA + distilled water 
• Test material in vehicle
• Test material in vehicle + FCA
• FCA + distilled water
• Vehicle
• Vehicle + FCA
Topical application  
day 7
Test material treatment 
with closed patch for 48h.
Vehicle treatment with 
closed patch for 48h.
Figure 8. The protocol for the guinea pig maximization test (GPMT) (8, 33, 47) with
sham-treated control animals.
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3.4.4 Cumulative contact enhancement test (CCET) [III, V]
The original description of CCET (Figure 9) (40) was followed, including the
modifications mentioned in section 3.4.2 [III, V]. Induction was carried out by four
topical applications (days 0, 2, 7 and 9) of 0.2 ml test substance in the shoulder
region (each application: 2x4 cm) for 24 h using an occlusive dressing as described
in the GPMT method and with two intradermal injections of 0.1 ml FCA (day 7) in
the same region. Challenge was performed as described in section 3.4.1.3.
Induction
FCA i.d.  x 2
FCA i.d.  x 2
Cumulative Contact Enhancement Test (CCET)
Exposed
animals
Control
animals
Closed patch testing  
day 22
Topical exposure of 
test material for 24h.
Challenge
Topical application
days 0, 2, 7, 9
Intradermal 
injection day 7
Test material treatment 
with closed patch for 24h.
Vehicle treatment with 
closed patch for 24h.
Topical exposure of 
test material for 24h.
Figure 9. The protocol for the cumulative contact enhancement test (CCET) (40) with
occluded challenge and sham-treated control animals.
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3.4.5 Freund's complete adjuvant test (FCAT) [III]
The FCAT (Figure 10) was performed as described originally (9, 36), with the
modifications mentioned in section 3.4.2 [III]. Induction was carried out by giving
three intradermal injections (day 0, 6, 10) of 0.1 ml of test substance in
FCA/vehicle (or FCA/water) emulsion (1:1). Challenge was performed as described
in section 3.4.1.3.
Induction
Test material in vehicle + FCA
Vehicle + FCA
Freund's Complete Adjuvant Test (FCAT)
Exposed
animals
Control
animals
Closed patch testing  
day 22
Topical exposure of 
test material for 24h.
Challenge
Intradermal 
injection days 0, 6, 10
Topical exposure of 
test material for 24h.
Figure 10. The protocol for the Freund's complete adjuvant test (FCAT) (9, 36) with
sham-treated control animals.
3.5 Statistical analysis [III-V]
3.5.1 Fisher’s exact test [V]
The results from the GPMT study in paper V were analyzed using Fisher’s exact
test (145-146).
3.5.2 Logistic regression analysis [III-V]
The statistical PC computer program "Program for multi-dose-response analysis",
i.e. a logistic regression analysis (65), included in the multi-dose-response
induction protocol developed for the GPMT (62) was used in papers III-V. This
computer program calculates and adapts the best fitted monotone or non-monotone
model curve to the observed sensitization rates in the experiments for the tested
substances, i.e. contact allergens. It also calculates chi-square (c 2) for goodness of
fit to the curve and dose-response relationship. The series of sensitization rates
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giving the best fit to the curve and a statistically significant dose-response was
usually chosen for further analysis.
The threshold concentration at sensitization was chosen empirically to be the
concentration giving at least the lowest possible sensitization rate of 0.125 (one
animal out of eight), and this sensitization rate was used in the analysis. The
maximal sensitization rate was decided to be the highest number of sensitized
animals obtained in any experiment group at the chosen induction and challenge
series [III, V] or sensitization criterion [IV]. The estimated concentration sensitizing
50% of the animals (EC50) was calculated by the program. Since the program failed
to calculate the threshold concentration and EC50 for the non-monotone dose-
response curves, these curves were cut at the point where they started to decrease
[III, V]. This procedure resulted in monotone curves with fewer induction
concentrations, from which it was possible to calculate the parameters mentioned.
The obtained monotone dose-response curves, which were similar to the non-
monotone dose-response curves given, were used for the calculations in paper IV.
3.6 Patch testing in patients [V]
Patients referred to and examined at the Department of Occupational and
Environmental Dermatology in Stockholm, were tested with a standard series and
with products and materials from their work environment. The concentrations of the
substances used are shown in the results section (Table 14). Finn chambers®
(Epitest Ltd Oy, Tussula, Finland) on Scanpor® tape (Norgesplaster AS, Norway)
were used and the exposure time was 48 h (7). The readings took place on 2
occasions- on Day 3 (24 h after removal of the patches) and on Day 5-7. The test
reactions were recorded according to the ICDRG (147).
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4. Results
4.1 Prediction of sensitizers using the LLNA [I-II]
4.1.1 The outcome with eight allergens and six irritants [I-II]
The ability of the predictive test method, LLNA, to discriminate between allergens
and irritants was investigated by testing 14 chemicals. In paper I, seven of eight
allergens and all five irritants tested were classified as sensitizers using the LLNA
(Figure 11). The contact allergens known to be moderate to potent sensitizers in
guinea pigs (DNFB, oxazolone, DNCB, t-cinnamic aldehyde, 2-
mercaptobenzothiazole, p-PDA) all gave clear positive results and showed a dose-
response relationship (Table I in  paper I). The SI-values of the less potent contact
allergens HC and benzocaine, were, respectively, slightly above (SI=3.4) and
slightly below (SI=2.9) the limit (SI=3) for being classified as allergens in the
LLNA. The five irritants tested (SDS, oxalic acid, methyl salicylate, the non-ionic
surfactant Triton X-100 and a mixture of chloroform/methanol (2:1)) gave SI-values
above or equal to the limit (SI=3) and also showed a clear dose-response (Table II
in paper I).
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Figure 11.  Summary of test results using the LLNA of eight allergens: DNFB ( );
oxazolone ( ); DNCB ( ); t-cinnamic aldehyde ( ); 2-mercaptobenzothiazole
( ); p-PDA ( ); HC ( ); benzocaine ( , almost totally obscured by HC) and five
irritants: SDS ( ); oxalic acid ( ); methyl salicylate ( ); Triton X-100 ( );
nonanoic acid ( ); chloroform/methanol (2:1) (not shown). The dotted horizontal
line (  ) shows three times the control value (SI=3). Data from Tables I and II
in paper I, and from Table II in paper II.
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In paper II, one additional irritant (nonanoic acid) (Figure 11) was tested and one
irritant (methyl salicylate) was re-tested in two different vehicles (Figure 12) in the
LLNA. Both irritants caused a dose-dependent increase in cell-proliferation and
according to the method, were classified as contact allergens when tested at higher
concentrations. The use of DMF or MEK as vehicles had only marginal effects on
the results (Figure 12 and Table I in paper II) and the proliferation activity in lymph
nodes of mice treated with either neat vehicle was just slightly increased compared
to that in naive mice (Table I in paper II).
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Figure 12. Test results obtained using the LLNA with methyl salicylate in the vehicles
MEK ( ) and DMF ( ).The experiments (1, 2, and 3a and 3b) were done on three
occasions and 3a and 3b were performed on the same occasions. The dotted
horizontal line ( ) shows three times the control value (SI=3). Data from
Table I in paper II.
4.1.2 SDS induced proliferation [I]
SDS was tested according to different schedules (3, 4, 5 or 6 days), in two
experiments, to investigate the time course of the proliferation induced in the
LLNA. A maximal or almost maximal proliferation was induced as early as 3 days
after the first application of SDS with an SI-value around 5 to 6, which was
maintained or slightly elevated at day 6 (Figure 13).
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Figure 13. Stimulation index of 10% SDS using the LLNA -  3, 4, 5 and 6 days after
the first of three daily applications. The horizontal line ( ) shows three times the
control value (SI=3). Data from Table III in paper I.
4.1.3 The addition of SDS to the test samples [I]
The effect of addition of SDS, an irritant, to the vehicle when testing two well
known allergens in LLNA was investigated. The proliferative activity of 10% SDS
in combination with different concentrations of the allergens HC and t-cinnamic
aldehyde was studied and compared with the proliferation caused by the same
concentrations of the allergens without SDS. There was a parallel shift upwards of
the dose-response curve for HC when 10% SDS was applied (Figure 14a). The
proliferative activity induced by SDS is added to the proliferation induced by the
allergen. The shift upwards of the dose-response curve of t-cinnamic aldehyde,
when 10% SDS had been applied, was slightly different (Figure 14b). The
proliferative activity induced by the combination of allergen and SDS was larger
than the sum of the proliferation they induced separately.
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Figure 14. The proliferation activity in the lymph nodes using the LLNA after
treatment with an allergen and after combined treatment with an irritant and an
allergen. a) HC ( ) and HC with 10% SDS ( ). b) t-cinnamaldehyde ( ) and t-
cinnamaldehyde with 10% SDS ( ). The horizontal lines ( ) and ( ) show
three times the control value with DMF and DMF + 10% SDS, respectively (SI=3).
Numbers on bars indicate SI values.
4.1.4 EC3 values for two irritants [II]
The application of LLNA to rank the relative skin-sensitizing potential of chemicals
was investigated. The relative potency is ranked as a function of the concentrations
required to give SI=3. This concentration is expressed as EC3 (estimated
concentration for SI=3). The EC3 for the two irritants, methyl salicylate and
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nonanoic acid, were read from the graph in Figure 1 in paper II and compared with
the EC3-values for five allergens and one irritant from the literature (Table 6).
Methyl salicylate and nonanoic acid were only slightly less potent inducers of
proliferation in the LLNA than the allergens eugenol, penicillin G, hexyl cinnamic
aldehyde, and HC.
Table 6. Relative activity of induced proliferation in local lymph node assay
(LLNA) for some allergens and irritants.
____________________________________________________________________
Substance EC3a References
___________________________
(%) (M)
____________________________________________________________________
DNCB 0.0765 0.00383 (148)
Eugenol 5.8 - 14.5 0.353 - 0.883 (142 )
HC 20 1.28 (149)
Hexyl cinnamic aldehyde 6.85 - 9.63 0.317 - 0.445 (150)
Methyl salicylate 15 - 65 0.99 - 4.27 (II)
Nonanoic acid 35 2.21 (II)
Penicillin G 20 0.561 (151)
SDS 1.5 - 17.1 0.052 - 0.593 (142)
____________________________________________________________________
a)EC3 value is defined as the concentration of the test material required to elicit a
stimulation index of three in the LLNA (142-143) and is given in % (w/v) and in mol/dm3 (M).
HC = hydroxycitronellal. SDS = sodium dodecyl sulfate.
4.2 Prediction of sensitizing capacities using a multi-dose-
response induction protocol in the GPMT, the CCET and the
FCAT [III]
4.2.1 Sensitization experiments with the model contact allergens
The application of the slightly modified multi-dose-response induction protocol on
three guinea pig models - GPMT, CCET and FCAT - was investigated. The model
contact allergens, K2Cr2O7 and HC, resulted in a clear sensitization of the exposed
animals when this protocol was applied. However, in the initial experiments testing
K2Cr2O7 in the GPMT and the CCET (nos. I and III, Table 5), almost a maximal
sensitization was attained in all exposed induction groups, groups 13-18 (data not
shown). This made it impossible to study dose-response relationships. Therefore,
the induction concentrations were lowered in the two following experiments with
the GPMT and the CCET and resulted in different numbers of positive reactions in
each experimental series. Re-challenge was done with K2Cr2O7 in the GPMT (no.
II, Table 5) and the CCET (no. III, Table 5) at 2 weeks and at 5 weeks after the first
challenge, respectively, and confirmed the sensitization results at the first challenge
(data not shown). A variable degree of dose-response was seen in all tests both for
the challenge concentration gradient and in the induction concentration gradient as
demonstrated with HC in CCET in Table II in paper III.
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4.2.2 Data assessment
The logistic regression analysis computer program in the protocol was used to
calculate which series of results from each sensitization experiment could give the
best fit to a dose-response curve. Those results are summarized in Table 7 and were
used for further dose-response analysis.
Table 7 Results from sensitization experiments using the multi-dose-response
induction protocol in the GPMT, CCET and FCAT.
____________________________________________________________________________
Challenge conc. for K2Cr2O7 Challenge conc. for HC
__________________________________ _________________________________
GPMT: 0.03% CCET: 0.1% FCAT: 0.1% GPMT: 3% CCET: 3% FCAT: 10%
___________ __________ __________ _________ _________ __________
Animals Group No. Group No. Group No. Group No. Group No. Group No.
pos/tested pos/tested pos/tested pos/tested pos/tested pos/tested
____________________________________________________________________________
Exposed 7 3/4 19 5/9 25 7/8 31 2/8 37 5/8 43 6/8
8 4/5 20 7/9 26 6/8 32 4/8 38 7/8 44 4/8
9 3/5 21 3/9 27 5/8 33 3/8 39 7/7 45 3/8
10 2/5 22 1/8 28 3/8 34 5/8 40 6/8 46 1/8
11 0/5 23 1/8 29 3/8 35 2/8 41 3/8 47 0/8
Control 12 2/5 24 0/8 30 1/8 36 0/8 42 2/8 48 0/8
____________________________________________________________________________
The data shown were those fitting best to one of the model curves and they were used for logistic
regression analysis (Table 8, Figures 15a-b).
The number of positive animals/number of tested animals at challenge for each induction group is
given. Further details are presented in Table 5. Allergens: potassium dichromate (K2Cr2O7) and
hydroxycitronellal (HC). GPMT = Guinea pig maximization test. CCET = Cumulative contact
enhancement test. FCAT = Freund's complete adjuvant test.
The best fitted dose-response curves for each of the methods - GPMT, CCET,
FCAT - are shown for K2Cr2O7 in Figure 15a and for HC in Figure 15b. The fitted
curves from the results with K2Cr2O7 were non-monotone for the GPMT and the
CCET and monotone for the FCAT. The fitted curves from the results with HC
were non-monotone for all three methods. A significant dose-response relationship
was found for the curves fitted from the CCET and FCAT for both model allergens.
However, no dose-response relationship was seen for the curves fitted from the
GPMT with the model allergens tested, due to divergent elicitation results.
The calculations of different parameters by the analysis computer program are
summarized in Table 8. The c 2 values for goodness of fit and dose-response
relationship, the maximal sensitization rate, the EC50 and the threshold concentration
for these six curves are given for a constant challenge concentration. There was no
clear pattern in the sensitivity of the three methods used. The FCAT was the most
sensitive test for K2Cr2O7 and gave the highest response rate and the lowest EC50
and threshold concentration. For HC the highest sensitization rate was seen in the
CCET, but the lowest EC50 and threshold concentration were seen in the GPMT.
None of these test methods could be recommended in preference to the others.
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Figure 15. Dose-response curves at constant challenge concentrations using the multi-
dose-response induction protocol on the guinea pig maximization test (GPMT) ( ),
the cumulative contact enhancement test (CCET) ( ), and the Freund’s complete
adjuvant test (FCAT) ( ) for a) Potassium dichromate (K2Cr2O7) and b)
Hydroxycitronellal (HC). Challenge reactions read at 72 h. Data from Tables 5 and 7.
The log10 for the vehicle control group, i.e. concentration 0% (filled symbols), is not
defined, but in the graph assigned a value by the computer program at the onset of
each curve by a factor of three from the lowest induction concentration used in each
experiment. (Figures reproduced with the permission from the publisher).
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Table 8. Results from sensitization experiments in guinea pigs using the multi-dose-
response induction protocol.
_______________________________________________________________________________
Allergen Methoda Ch. Statistical Max. rated EC50e TCf
conc.b sign.c (pos./exp.)_______________ ______________
% molal % molal
_______________________________________________________________________________
K2Cr2O7 GPMTg 0.03 ns 4/5 2.5x10-3 8.5x10-5 4.4x10-6 1.5x10-7
CCET 0.1 ** 7/9 4.2x10-3 1.4x10-4 6.6x10-4 2.2x10-5
FCAT 0.1 ** 7/8 4.5x10-4 1.5x10-5 1.1x10-7 3.7x10-9
HC GPMTg 3 ns 5/8 6.8x10-2 4.0x10-3 1.6x10-2 9.3x10-4
CCET 3 ** 7/7 1.8 1.1x10-1 0.31 1.8x10-2
FCAT 10 ** 6/8 0.89 5.2x10-2 7.2x10-2 4.2x10-3
_______________________________________________________________________________
Test results from the 72 h reading are used for the analysis; data from Tables 5 and 7. Allergens:
potassium dichromate (K2Cr2O7) and hydroxycitronellal (HC).
a)All methods followed the multi-dose-response induction protocol with a constant challenge
concentration.
b)Challenge concentration for the curve chosen.
c)All curves had a goodness of fit to the curve, i.e., c 2FIT, which was not significant (ns) and all
curves were accepted (Table 4 in paper III). The dose-response relationship, i.e. c 2D-R, was
calculated; ** p<0.01 or not significant (ns).
d)Maximal sensitization rate. The maximal number of animals with a positive reaction/number of
animals exposed.
e)Estimated concentration. Calculated induction concentration sensitizing 50% of the animals,
given in % (w/w) and molal (mol/kg).
f)Threshold concentration. Lowest induction concentration that can sensitize, given in % (w/w) and
molal (mol/kg). Chosen empirically to be at the least the animal response rate 1/8=0.125.
g)Calculated values using results from the GPMT method were based only on the id administration.
GPMT = Guinea pig maximization test. CCET = Cumulative contact enhancement test. FCAT =
Freund's complete adjuvant test.
4.3 Sensitization results using a multi-dose-response induction
protocol in a modified MEST [IV]
4.3.1 Sensitization experiments with four allergens and one irritant
The application of an adjusted multi-dose-response induction protocol on a modified
MEST was evaluated with four chemicals previously identified as contact allergens:
oxazolone, K2Cr2O7, MDBGN and HC, and the irritant oxalic acid. Different
sensitization criteria were used to obtain a variable degree of dose-response
relationship with the induction concentration gradients used for the substances
tested (data not shown), as is exemplified with the strong contact allergen oxazolone
(positive control) in Table 1 in paper IV. The relative ear thickness after application
of the test substances was calculated for the different induction groups at the
sensitization criteria chosen by the statistical analysis (section 4.3.2) (Table 9). A
clear increase in the relative ear thickness was seen with oxazolone (up to 30 %) and
K2Cr2O7 (up to 11 %), while no or possibly slight increases were shown for the
other substances tested. Data from literature on the relative ear thickness and
sensitization rates were compared with our results for some of the substances tested
(Table 10).
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Table 9. Results from the modified mouse ear swelling test (MEST) with the test
substances using the multi-dose-response induction protocol. The relative ear
thicknesses for the respective induction groups are also given.
______________________________________________________________________________
Substance Challenge Induction Sens. Measuring Sens. rate Relative ear
conc.a conc.a criterionb time (pos/exp) thickness(%)
(w/v %) (w/v %)
______________________________________________________________________________
Oxazolone 0.3 AOO 15 % 48 h 0/8 104
in AAO 0.0003 2/8 108
0.003 5/8 115
0.03 7/8 119
0.3 8/8 130
K2Cr2O7 0.3 DMSO 10 % 24 h 1/8 104
in DMSO 0.03 4/8 107
0.1 5/8 108
0.3 7/8 111
1.0 5/6 110
MDBGN 3 DMF 5 % 48 h 2/6 103
in DMF 0.3 2/8 102
1.0 5/7 105
3.0 6/7 103
HC 10 DMF 10% 24 h 0/8 103
in DMF 3 0/8 104
10 1/8 105
30 1/8 103
100 2/8 105
Oxalic acid 0.3 DMF 10% 48 h 0/8 99
in DMF 0.1 1/7 103
0.3 1/7 103
1.0 0/7 100
______________________________________________________________________________
The sensitization rates were further used in the dose-response analysis (Table 11 and Figure 16a-c).
Induction and challenge: Oxazolone was applied topically in acetone/olive oil, 4:1 (AOO) at
induction and in acetone/arachis oil, 4:1 (AAO) at challenge. Potassium dichromate (K2Cr2O7) was
applied topically in dimethylsulfoxide (DMSO). Methyldibromo glutaronitrile (MDBGN),
hydroxycitronellal (HC), and oxalic acid were applied topically in dimethylformamide (DMF).
a)HC was applied topically; concentrations are given in v/v %.
b)Series of sensitization rates were chosen on the basis of hypothetical sensitization criteria in
percent. Usually the series that gave the best fit to a model curve and a statistically significant
dose-response relationship was chosen. If no statistical significance was obtained the results were
presented at a 10% (no irritation in pretest) sensitization criterion.
33
Table 10. Results obtained with the contact allergens tested in the modified mouse ear
swelling test (MEST) using a multi-dose-response induction protocol. For
comparison, literature data from mouse assays using MEST methodology are also
presented.
_______________________________________________________________________________
Substance Ind. No. appl.b Ch. Vehiclesd Relative Sens. Statistical References
conc.a conc.c ear rate (%) sign.e
(%) (%) thickness (%)
________________________________________________________
Oxazolone 0.3 3 0.3 AOO, AAO 130 100 *** paper IV
Oxazolone 5.0 4 0.1 Ac 134 100 nd 1986 (68)
Oxazolone 3.0 3 0.1 Ac 140 nd ** 1988 (70)
Oxazolone 0.1 4 0.1 Ac 161 100 ** 1993 (152)
K2Cr2O7 1.0 3 0.3 DMSO 111 88 ** paper IV
K2Cr2O7 2.0 4 2.0 25% EtOH 114 40 nd 1986 (68)
K2Cr2O7 2.0 3 2.0 EtOH 109 nd * 1988 (70)
MDBGN 3.0 3 3.0 DMF 105 86 * paper IV
HC 100 3 10 DMF 105 25 ns paper IV
HC 30 6 20 AOT nd nd *** 1986 (67)
HC 25 6 20 MEK nd nd *** 1991 (81)
_______________________________________________________________________________
Contact allergens: 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone), potassium
dichromate (K2Cr2O7), methyldibromo glutaronitrile (MDBGN), and hydroxycitronellal (HC).
Vehicles: Acetone (Ac), acetone:arachis oil, 4:1 (AAO), acetone:olive oil, 4:1 (AOO),
acetone:oil:Tween 80, 4:3:1 (AOT), dimethylsulfoxide (DMSO), dimethylformamide (DMF),
ethanol (EtOH), methyl ethyl ketone (MEK).
a)The induction concentration (highest) used.
b)Number of topical treatments applied.
c)The challenge concentration used.
d)The vehicles used at induction and challenge.
e)Statistical significance of the test results with the statistical analysis used in each respective
study.
*** p < 0.001, ** p < 0.01, * p < 0.05 and not significant (ns).
nd = not determined.
4.3.2 Data assessment
The resulting sensitization rates in the induction groups for all substances tested at
the various sensitization criteria are shown i Table 9. These data represent in general
the best fit to the model curves using the logistic regression analysis computer
program and the sensitzation rates were used further in the analysis of the results.
This protocol could detect the moderate to strong contact allergens, i.e. oxazolone
and K2Cr2O7. and the weak contact allergen MDBGN as sensitizers. A significant
dose-response relationship was obtained for the fitted curves for these contact
allergens (Table 11). The sensitization rates for oxazolone at a 15 % sensitization
criterion gave a good fit to a non-monotone curve (Table I in paper IV, Tables 9, 11
and Figure 16a). A slightly better fit of the sensitization rates for oxazolone to a
monotone curve at 10 % sensitization criterion with a statistically significant dose-
response relationship was also obtained. However, this curve was not chosen,
since several of the sensitization rates were at maximum giving a smaller spread of
the sensitization rates in the interval of induction concentrations tested (data not
shown). The sensitization rates obtained for K2Cr2O7 gave a fitted non-monotone
curve at the 10 % sensitization criterion (Tables 9, 11 and Figure 16b). No curve
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could be fitted to the sensitization rates for MDBGN at a 10 % sensitization criterion
due to the low increases in the relative ear thickness (Table 9). The sensitization
rates for MDBGN at a 5 % sensitization criterion were used in the analysis and gave
an acceptable fitted monotone curve (Tables 9, 11 and Figure 16c).
Table 11. Sensitizing potential of five chemicals in the modified mouse ear swelling
test (MEST) using a multi-dose-response induction protocol.
_______________________________________________________________________________
Substance Sensitization Statistical Max. ratec EC50d TCe
criteriona significanceb (pos./exp.) ____________ ________________
(%) (M) (%) (M)
_______________________________________________________________________________
Oxazolone 15 % *** 8/8 0.002 9.2x10-5 1.0x10-4 4.6x10-6
K2Cr2O7 10 % ** 7/8 0.03 6.8x10-4 8.4x10-7 2.9x10-3
MDBGN 5 % * 6/7 0.7 2.6x10-2 0.04 1.5x10-3
HC 10 % ns 2/8 nd nd nd nd
Oxalic acid 10 % ns 1/7 nd nd nd nd
_______________________________________________________________________________
Data from Table 9. Dose-response curves are shown in Figures 16a-c. Allergens: oxazolone,
potassium dichromate (K2Cr2O7), methyldibromo glutaronitrile (MDBGN), and hydroxycitronellal
(HC). Irritant: oxalic acid.
a) Series of sensitization rates were chosen on the basis of hypothetical sensitization criteria in
percent. Usually the series that gave the best fit to a model curve and a statistically significant
dose-response relationship was chosen. If no statistical significance was obtained the results were
presented at a 10 % (no irritation in pretest) sensitization criterion.
b)All presented curves had a goodness of fit to the curve, i.e. c 2FIT, which was not significant (ns)
and the curves were all accepted (Table III in paper IV). The dose-response relationship, i.e. c 2D-R,
was calculated; *** p<0.001, ** p<0.01, * p<0.5 and not significant (ns).
c) Maximal sensitization rate. The maximal number of animals with a positive reaction/number of
animals exposed.
d) Calculated induction concentration sensitizing 50 % of the animals, given in percent (w/v) and M
(mol/L). For substances not giving a statistically significant dose-response calculations were not
done (nd).
e) Lowest induction concentration that can sensitize, given in percent (w/w) and M (mol/L). Chosen
empirically to be at the least the animal response rate of 1/8=0.125. For substances not giving a
statistically significant dose-response calculations were not done (nd).
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The sensitizing capacities of the contact allergens - oxazolone, K2Cr2O7 and
MDBGN - are shown in Table 3, where the values for threshold concentration for
sensitization, EC50 and maximal sensitization rate are given. However, no
statistically significant dose-response relationship could be confirmed for the weak
contact allergen, HC. A ‘negative’ response was obtained with the irritant, oxalic
acid (negative control), at the concentrations tested (Table 9, 11).
4.4 The allergenicity of a preservative according to different test
methods (V)
The allergenicity of Euxyl K 400 and one of its ingredients MDBGN was
investigated using three different predictive test methods, the GPMT, the CCET
using a slightly modified multi-dose-response induction protocol, and the LLNA.
The ability of these three test methods to detect the allergenicity of the Euxyl K 400
and/or MDBGN varied.
4.4.1 Sensitization experiment with GPMT
Sensitization with MDBGN gave a few positive reactions at the challenge concen-
tration 1% MDBGN in OO and a single positive reaction was also seen with the
challenge concentration 1% MDBGN in PE (Table 12). However, no statistically
significant sensitization was induced by MDBGN in OO or in PE at any concen-
tration tested. The challenge concentration 3% MDBGN in OO, which gave minimal
irritation in the irritancy threshold study, was also included in the test. However,
some of the control animals reacted to this concentration (data not shown).
Table 12. Results from sensitization studies in guinea pigs according to the guinea pig
maximization test (GPMT) using methyldibromoglutaronitrile (MDBGN) for
inductiona.
____________________________________________________________________________
Challenge materialb
________________________________________________
MDBGN (% in OO) MDBGN (% in PE)c
___________________________ __________________
Guinea pigs 1 0.3 0.1 OO 1 0.3 PE
_____________________________________________________________________________
Exposed 3 1 0 0 1 0 1
(n=15)
Control 0 0 1 1 0 0 0
(n=15)
p exposed/control ns ns ns ns ns ns ns
_____________________________________________________________________________
The number of animals with positive reactions at 72 h after test application is given.
a)Induction: MDBGN 0.1% in arachis oil intradermally and MDBGN 10% in arachis oil topically
(w/w).
b)Challenge material: MDBGN in olive oil (OO) or MDBGN in phenoxyethanol (PE) (w/w).
c)Euxyl K 400 (20% MDBGN:80% PE) was diluted with additional PE to obtain the concentrations
of MDBGN used.
ns: not significant
37
4.4.2 Sensitization experiment with CCET using a multi-dose-
response induction protocol
Various dose-response relationships were seen among the guinea pigs sensitized
with MDBGN in the different induction groups at the challenge concentrations used
(Table 2 in paper V). The induction series and challenge series chosen for further
analysis were the series with numbers of positive test reactions (sensitization rates)
giving the best fit to the model curves. Curves with a significant dose-response
were obtained for both the induction series at a constant challenge concentration of
3% (Figure 17 and Table 13) and the challenge series at a constant induction
concentration of 3 % (Figure 1b in paper V and Table 13). The dose-response curve
was non-monotone for the induction series (Figure 17) and monotone for the
challenge series (Figure 1b in paper V). The sensitizing potential of MDBGN is
presented in Table 13, as are the maximal sensitization rate, the EC50 and the
threshold concentration for sensitization for these curves.
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Figure 17. Dose-response curve obtained for methyldibromo glutaronitrile
(MDBGN) at a constant challenge concentration of 3 % using the multi-dose-
response-induction protocol in the cumulative contact enhancement test (CCET).
Challenge reactions read at 72 h. Data from Table 2 in paper V. The log10 for the
vehicle control group (concentration 0%) is not defined, but in the graph assigned a
value by the computer program at the onset of the curve. P0 = baseline for statistical
calculations. (Figure reproduced with the permission from the publisher).
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Table 13. Sensitizing capacity of methyldibromoglutaronitrile (MDBGN) in guinea
pigs according to the cumulative contact enhancement test (CCET) using a dose-
response protocol.
_____________________________________________________________________________
Constant Conc.b Statistical Max. rated EC50e TCf
conc.a used for (%) sign.c (pos./exp.) ____________ ______________
% molal % molal
_____________________________________________________________________________
Challenge 3 ** 8/8 1.9 7.2x10-2 0.3 1.2x10-2
Induction 3 *** 6/8 0.7 2.8x10-2 0.02 8.6x10-4
_____________________________________________________________________________
Data from Table 2 in paper V.
a)The dose-response protocol was followed; either the challenge concentration or the induction
concentration was constant.
b)Challenge or induction concentration for the curve chosen.
c)All the curves had a goodness of fit to the curve, i.e., c 2FIT, which was not significant (ns) and
all the curves were accepted. The dose-response relationship was calculated, c 2D-R, ** p<0.01 and
*** p<0.001.
d)Maximal sensitization rate. The maximal number of animals with a positive reaction/number of
animals exposed.
e)Calculated induction concentration sensitizing 50% of the animals, given in % (w/w) and molal
(mol/kg).
f)Lowest induction concentration that can sensitize, given in % (w/w) and molal (mol/kg). Chosen
empirically to be at the least the animal response rate 1/8=0.125.
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4.4.3 Sensitization experiment with LLNA
The proliferation induced in the lymph nodes by Euxyl K 400 and MDBGN
showed a dose-response relationship (Figure 18). Both Euxyl K 400 and MDBGN
diluted in DMF or PE gave SI-values above three at the test concentration 5% and
they were classified as sensitizers (Figure 18, Table 4 in paper V). The resulting
lymph node weights and the [3H]thymidine incorporation are also shown in Table 4
in paper V.
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Figure 18. Proliferation induced by methyldibromo glutaronitrile (MDBGN) in
phenoxyethanol (PE) (experiment 1 = , experiment 2a = ) and in
dimethylformamide (DMF) (experiment 2b = , experiment 3 = ), in sensitization
experiments using the LLNA. Experiments 2a and 2b were performed on the same
occasion. For test with 20% MDBGN in PE, Euxyl K 400 was used. The dotted
( ) horizontal line shows three times the vehicle-treated control value (SI=3).
Data from Table 4 in paper V. (Figure reproduced with the permission from the
publisher).
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4.4.4 Patch testing of patients
The frequency and causes of positive patch test reactions to Euxyl K 400 and
MDBGN in patients with work-related contact dermatitis was also investigated to
make comparisons possible with the experimental data. The preservative Euxyl K
400 was included in the standard series 1991-1996 and one of its ingredients
MDBGN in 1996-1998. The patch testing of 1770 patients – referred due to work-
related contact dermatitis - resulted in nine with relevant positive reactions (Table
14). Seven patients were positive to Euxyl K 400 and two patients were positive to
MDBGN. The majority of those had been occupationally exposed (V), by using
soaps, shampoos, creams, lotions or cleansing agents. One case was related to an
adhesive and one to a cutting fluid containing MDBGN. There were also nine
unexplained positive reactions to Euxyl K 400. The total frequency of positive patch
test reactions varied between 0.9 and 1.8 % (Table 14) and more detailed data are
presented in Table 5 in paper V.
Table 14. Patch test results with Euxyl K 400 and methyldibromo glutaronitrile
(MDBGN) when included in the standard series at an occupational dermatology
clinic.
___________________________________________________________________________
Total pos.
Test Conc. Test _______________ Relevance
preparation (% in pet.) period n % n
__________________________________________________________________________
Euxyl K 400 0.1 Dec-91 - Sept-92 3 1.4 1
Euxyl K 400 0.5 Aug-93 - Aug-95 5 0.9 3
Euxyl K 400 1.0 Sept-92 - Aug-93 8 1.8 3
Aug-95 -April-96
MDBGN 0.3 April-96 -Dec-98 7 1.3 2
__________________________________________________________________________
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4.5 The estimated sensitizing potentials of the tested substances
and human data from literature [I-V]
The sensitizing potentials of all the substances studied in this thesis were estimated
and used for comparison of the five predictive test methods used. The estimated
sensitizing potentials were based on the degree of sensitization among the
experimental animals in each test method, and the concentrations used were also
taken into consideration (Table 15). Published patch test results from dermatitis
patients are also presented for comparison (Table 15).
Table 15. Summary of the substances tested in the predictive animal test methods
used in this thesis. The degree of the sensitization response (+++ = marked, ++ =
medium, + = low and - = negative) in each test method used was estimated for each
test substance, taking into account the concentration range over which the substance
was tested within a test method.
The allergens and the irritants are presented in alphabetic order.
_______________________________________________________________________________
Predictive animal test methods
___________________________________________________ Patch test
Substances GPMT CCET FCAT LLNA MEST resultsa
(references)
_______________________________________________________________________________
Allergensb:
Benzocaine nt nt nt (-) nt 1.7 % (10)
t-CN nt nt nt +(+) nt 10.2 % (153)
DNCB nt nt nt +++ nt positive (154)
DNFB nt nt nt +++ nt positive (155)
HC ++ +++ ++(+) + - 10.2 % (153)
K2Cr2O7 ++(+) ++ +++ nt + 4.6 % (10)
2-MBT nt nt nt ++ nt 0.9 % (10)
MDBGN - +++ nt +(+) (+) 1.7 % (10)
Oxazolone nt nt nt +++ +++ nt
p-PDA nt nt nt ++ nt 5.0 % (10)
Irritantsc:
Chloroform nt nt nt + nt negative (156)
/MeOH
MS nt nt + nt - negative (156)
NNA nt nt nt + nt negative (157)
Oxalic acid nt nt nt + - negative (156)
SDS nt nt nt + nt negative (158)
Triton X-100 nt nt nt + nt negative (159)
_______________________________________________________________________________
a)Patch testing was performed in dermatitis patients.
b)Contact allergens: Benzocaine, T-cinnamic aldehyde (t-CN), 2,4-dinitroclorobenzene (DNCB), 2,4-
dinitrofluorobenzene (DNFB), hydroxycitronellal (HC), potassium dichromate (K2Cr2O7), 2-
mercaptobenzothiazole (2-MBT), methyldibromo glutaronitrile (MDBGN), 4-ethoxymethylene-2-
phenyl-2-oxazolin-5-one (Oxazolone), p-phenylenediamine (p-PDA).
c)Irritants: Chloroform/MeOH, methyl salicylate (MS), nonanoic acid (NNA), Oxalic acid, sodium
dodecyl sulfate (SDS), Triton X-100.
Animal test methods: the guinea pig maximization test (GPMT), the cumulative contact
enhancement test (CCET), the Freund’s complete adjuvant test (FCAT), the local lymph node
assay (LLNA), the mouse ear swelling test (MEST)
not tested = nt
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5. General discussion
In this thesis predictive test methods for contact allergy were investigated. A slightly
modified multi-dose response induction protocol was applied to three guinea pig
predictive test methods - the GPMT, the CCET and the FCAT - and evaluated with
two model allergens. The application of a multi-dose response induction protocol on
a modified predictive test method in mice – the MEST - was evaluated with some
allergens and one irritant. A predictive test method in mice - the LLNA - was
evaluated with both allergens and irritants. The ability of three predictive test
methods – the GPMT, the CCET using a slightly modified multi-dose response
induction protocol, and the LLNA - to detect the allergenicity of a preservative was
studied and the results were compared with results from patch tests in dermatitis
patients. The predictive test methods were also compared with each other based on
the results from the substances studied.
5.1 Evaluation of a slightly modified multi-dose-response
induction protocol on three guinea pig models [III]
A multi-dose-response induction protocol has been developed and evaluated for the
GPMT to improve the power of predictive tests for contact allergens (62). It is
combined with a statistical computer program, i.e. logistic regression analysis,
which uses all available test results in the analysis of the results (65). Some studies
done with this protocol can be found in the literature (61, 63). The protocol has also
been evaluated in some other extended dose-response studies using the GPMT (64,
160). This protocol, slightly modified with an increased number of animals in each
experimental group and an increased number of challenge concentrations, was
applied to three predictive guinea pig methods - the GPMT (33), the CCET (40) and
the FCAT (36) - using two model contact allergens (paper III). These methods have
different induction procedures; the GPMT uses both topical and intradermal
administration, the CCET uses topical administration only and the FCAT uses
intradermal administration only. The multi-dose-response induction protocol (62)
was easily applied on the CCET and the FCAT since they have only one induction
route, where the test substance can be administered in an increasing concentration
gradient. Fitted curves with a significant dose-response for the model allergens
were obtained. However, the GPMT has two induction routes - intradermal and
topical - and when the multi-dose-response induction protocol was used (62), the
intradermal administration was given in an increasing concentration gradient and the
topical administration was given at two concentrations (one higher and one lower)
which were alternated between the induction groups (62). The topical administration
influenced the results in the GPMT with the model allergens and gave inconsistent
results (Table 7). No dose-response could be seen in those fitted curves (Figure
15a-b and Table 8). Our interpretation is that the respective influences of intradermal
and topical exposure vary with the chemical under study, an interpretation which is
also discussed elsewhere (61). Adjustment of the induction procedure for the
GPMT so that it can handle two increasing concentration gradients is desirable. This
is indicated in a previously published report (161).
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The logistic regression analysis PC computer program (65) was used to obtain
the best fitted dose-response curves for each of the experiment series. The fitted
curve with K2Cr2O7 was monotone for the FCAT. Monotone dose-response curves
have been seen in earlier published studies using GPMT with cinnamic aldehyde
(62-63), mercaptobenzothiazole (62), and methyl methacrylate (64). Non-monotone
fitted curves were obtained with K2Cr2O7 for the GPMT and the CCET and with
HC for all three sensitization methods used (paper III). Non-monotone dose-
response curves have been reported in studies using GPMT with formaldehyde (61-
64), mercaptobenzothiazole (62-63) and nickel sulphate (161). The dose-response
relationship was significant for the curves fitted from the CCET and FCAT, but no
dose-response relationship was seen for the curves fitted from the GPMT for the
two model allergens tested. This is in contrast to previously published studies with
this multi-dose-response induction protocol using the GPMT (61-64, 161).
However, it is consistent with one other independent study using the GPMT to
examine the effect of Tween®  80 (162).
Occasional reactions due to irritation were seen at challenge test sites in the
control animals as well as in the vehicle controls (paper III), and are a matter of
concern (55-59, 163-165). The number of animals was increased in each group, a
confluent erythema was chosen as the criterion for a positive reaction and the
readings from 72 h were chosen to minimize the influence of irritation in data
assessment. Nonetheless, the base levels (P0) were slightly influenced due to these
irritation reactions in a few curves (Figures 15a-b). Re-challenge was done with
K2Cr2O7 in the GPMT and CCET, and confirmed the results obtained at the first
challenge (data not shown). The value of re-challenge has earlier been discussed
and it was concluded that the GPMT can benefit from this procedure to verify a
sensitization or if positive reactions have been observed in the sham-treated controls
at the first challenge (58, 164, 166-167). However, new controls should be added.
One important advantage of this multi-dose-response induction protocol (62),
compared to standard single dose administration (33, 36, 40), is that it minimizes
the risk of using an induction concentration that is too high and giving a result in the
down slope portion of a non-monotone dose-response curves. Multiple
concentrations have been used in many earlier studies at induction (168-169), at
challenge (170-172) or at both (9, 173-176) and a dose-response relationship is
generally seen. Visualization of those results is usually done graphically (161, 175),
but without the aid of a logistic regression analysis computer program much
information is lost. However, when following the original recommendations for
induction concentrations in the dose-response induction protocol (62), the initial
experiments with K2Cr2O7 in the GPMT and the CCET (nos. I and III, Table 5)
gave an almost maximal sensitization at all the induction concentrations used (data
not shown). This was also shown for Kathon CG, another potent sensitizer, using
the same multi-dose-response induction protocol (62-63). The induction
concentrations were then lowered in the following two experiments with the GPMT
and CCET and resulted in various numbers of positive reactions in each
experimental series (Table 7). The modification using a challenge concentration
gradient, instead of only one test concentration according to the protocol (62),
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minimizes the risk of obtaining a weak elicitation reaction or no reaction at all in
sensitized animals.
Modifying the protocol by increasing the number of animals in each experimental
group (6 groups with 8 animals in each) partly counteracts the original objective of
better use of the same number of animals (6 groups with 5 animals in each
compared to 2 groups with 15 animals in each), but as it makes the result more
reliable and minimizes the influence of occasional false positive reactions, it is an
alteration worth considering (145). Obtaining information on suspected contact
allergens tested in sensitization studies, i.e. a threshold concentration for
sensitization, a maximal sensitization rate and an EC50, should be of great value for
risk assessment of allergens.
It can be concluded that the dose-response protocol was easily applied to the
CCET and FCAT, which have only one exposure route, and where the logistic
models could be fitted to the data. However, for the GPMT with two exposure
routes, the topical doses at induction interacted with the logistic model. The protocol
would benefit from further developments: A linear increase should be included for
the topical application as for the intradermal application at induction in the GPMT.
The induction doses should - when necessary - be lowered. Further challenge
concentrations should be included. The ability of the computer program to calculate
threshold concentration and EC50 for non-monotone curves should be extended.
5.2 Evaluation of a multi-dose-response induction protocol
applied on a modified mouse ear swelling test [IV]
The MEST has been standardized and evaluated in order to be used for prediction of
the skin sensitizing potential of environmental chemicals (68). It has some
advantages compared to the guinea pig test methods, concerning speed, labor-
intensiveness and cost, and the use of an objective end point. The assays using
MEST methodology have been further evaluated (67, 70, 73, 79, 81, 83, 152, 177-
178), and compared with guinea pig test results (80, 179) and human test results
(180). However, doubts have been raised about the method’s ability to detect weak
and moderate contact sensitizers when the original MEST protocol is used (79), and
some modifications in the MEST methodology have been introduced over the years.
Some studies have been able to detect weak to moderate contact allergens by
including smaller modifications together with vitamin A acetate (VAA)
supplemented diet (73, 83), whereas others, despite their efforts to include
modifications to obtain a more sensitive test method, did not manage to detect all the
weak and moderate sensitizers tested (70, 152, 177).
The MEST performed in this study (Figure 6-7) was a modification of the
original MEST protocol (Figure 4a) (68). VAA supplemented diet was used to
enhance the sensitivity of the MEST, as it has been shown in several studies to
increase the sensitivity of the predictive test method (72-73, 82-84). The induction
was performed on the back, which in some studies has been shown to induce a
higher sensitization rate of the animals (unpublished result, 78, 84) than when the
original protocol is followed. The number of topical applications was reduced to
three as done in other MEST studies (78, 118-119, 122, 181). Challenge was
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performed at day 9 (5 days after last application at induction). This interval of 5
days from induction to challenge was used in the modified MEST protocol by Gad
(Figure 4b) (75), and also in some other studies (72-73, 78, 182). In the present
study the challenge was performed by application of test substance on both ears as
also described earlier (67, 81-83, 118), instead of using only one ear for the test
substance and the other ear for the vehicle control. The reason for this was that the
mice may redistribute the substances applied on the different ears through their
natural grooming behavior and therefore the application of the vehicle control was
omitted. The sensitization criterion for the test substances was set to be at a higher
level than the increases in ear thickness induced by irritation. The modifications are
discussed in more detail in paper IV.
A multi-dose-response induction protocol developed for the GPMT (62) was
slightly adjusted for the application to this modified MEST protocol. Following the
dose-response protocol and the earlier evaluation of the protocol (section 5.1) the
test animals were divided into five groups with eight animals in each. Relative
increases of ear thickness were calculated for each animal, since the statistical
analysis, i.e. the logistic regression analysis, has to assess the data on a relative
basis in each individual animal. A sensitization criterion of at least a relative increase
in ear thickness of 20 % as in the original MEST (68) was considered to be too
great an increase, since the individual variation of ear thickness was not taken into
account. Hypothetical sensitization criteria were introduced and a sensitization was
considered to have occurred if at least one ear on one or more animal, had at
minimal a relative increase in thickness corresponding to the statistically chosen
sensitization criterion. The advantage of this statistical program is that it makes it
possible to analyze different series of sensitization data and to determine which
series gives the best fit to the available model curves (62).
Four chemicals, previously identified as contact allergens, and one irritant were
used for the evaluation in the present study and some sensitization data with dose-
response relationships were obtained (data not shown). Dose-response relationships
for contact allergens are well known and have been demonstrated in various studies
using both guinea pig (section 5.1) (161, 170, 172, 175) and mouse (section 5.2-
5.3) (72-73, 180, 182-183) predictive test methods. However, an additional
advantage of this logistic regression analysis is that it uses all the obtained
experimental data from the different induction groups to calculate the significance of
the dose-response. In several studies of the sensitizing properties of potent
sensitizers, a non-monotone dose-response curve was seen (72-73, 180, 182-183).
In those studies, the data were analyzed with linear regression analysis, but the
application of the present logistic regression analysis would most likely have given
additional information. In the dose-response analysis of our data, different
sensitization criteria had to be used. It was shown that with a stronger sensitizer a
higher sensitization criterion could be used. A monotone dose-response curve was
obtained for the weak contact allergen MDBGN at a 5 % sensitization criterion
(Figure 16c). This sensitization criterion was lower than the allowed 10 % increase
in ear thickness due to irritation from the challenge application. However, this 5 %
sensitization criterion gave a statistically accepted curve with a statistically
significant dose-response relationship, which could not be obtained with a 10 %
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sensitization criterion. The non-monotone dose-response curves (section 5.1)
obtained for the strong and moderate contact allergens, i.e. oxazolone (the positive
control) (Figure 16a) and K2Cr2O7 (Figure 16b), were quite similar to the monotone
curve. For these two last contact allergens, a dose-response curve could be obtained
at a 10 % sensitization criterion, however, a better curve was found with the 15 %
sensitization criterion for oxazolone. The irritant reactions (the ‘sensitized’ mice) in
the control groups for K2Cr2O7 and MDBGN were also included in the calculations
of the dose-response curves and because of them the statistical program made small
adjustments of the baseline (P0) in the data assessment (Table 9 and Figures 16b-c).
The obtained dose-response curves were used for further calculations of the
sensitizing capacity for the tested substances (Table 11), e.g. the estimated
concentration sensitizing 50 % of the animals (EC50). This parameter can be
compared to some earlier studies using ”the estimated dose to cause 50 %
sensitization” (SD50), which, however, has only been interpolated from plots (72-
73, 180, 182-183).
The sensitizing potential of three of the tested contact allergens (Table 11) shows
that the highest sensitization rate and lowest EC50 are seen for oxazolone (a common
strong experimental contact allergen in animals) and followed by the moderate
contact allergen K2Cr2O7 and the weak contact allergen MDBGN. The observations
for the last mentioned allergens are in accordance with human data (10). However,
the threshold sensitization concentration for K2Cr2O7 was, in this study, lower than
the one for oxazolone. The weak contact allergen, HC was not detected as a
sensitizer using this modified MEST (Table 11) in contrast to human data (10). HC
gave only a few sensitization reactions and a minimal relative increase in ear
thickness (Table 9). The irritant (negative control), i.e. oxalic acid was correctly
shown to give a ‘negative’ response using the modified MEST protocol (Table 11).
Only occasional irritant reactions were seen and no relative increase in ear thickness
in the induction groups was detected (Table 9).
During the interpretation of the results from earlier studies, different methods or
no statistical methods at all have been used. This makes comparisons of our test
results to the test results from other studies difficult to perform. Relative ear
thickness for each test substance was for this reason calculated for the induction
groups using measurements of all exposed ears (Table 9). Some of our results of
the contact allergens tested were compared with literature data (Table 10), which
showed a relatively good correlation between our test results and other test results.
It is likely, however, that HC has to be applied more than three times topically at
induction and that a higher challenge concentration had to be used than the one used
in this study (10 %), since a sensitization was obtained after six topical applications
with a challenge of 20 % (67, 81).
It can be concluded that this modified MEST using the dose-response protocol
could detect the tested moderate to strong contact allergens as sensitizers, but not
one of the two weak contact allergens. The irritant (negative control) gave a
‘negative’ response.
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5.3 Evaluation of the local lymph node assay [I-II]
The LLNA has been developed to be used as a predictive test method for contact
allergens (90). It offers many advantages over guinea pig methods regarding speed,
labor-intensiveness and cost, and gives an objective end result not affected by the
color of the chemical tested (71). It has been used in several studies for prediction
of the allergenic potential of substances (152, 184-185). The method has been
extensively evaluated in inter- and intralaboratory studies (89, 186-190), with
human maximization test results (191), and in comparative studies with guinea pig
methods (89, 186-187, 192-193). It has been shown to identify moderate to strong
allergens and some weak allergens (86, 193-194). However, the ability of this
assay to discriminate between weak allergens and irritants has been questioned and
an increasing number of substances, considered to be non-sensitizers, have been
shown to induce cell-proliferation in the LLNA (paper I, 81, 149, 185, 194-195).
Nonetheless, during a meeting in the USA for the Interagency Coordinating
Committee on the Validation of Alternative Methods (ICCVAM) in 1998, the peer
review panel recommended the LLNA as a stand-alone alternative for predictive
testing of contact allergens (196). However, eight modifications must be included in
the protocol, e.g. the mice should be assessed individually, statistical analysis
should be performed and the classification for a sensitizer should include a SI ‡  3, a
statistical significance and dose-response information (196).
Use of the LLNA for predictive testing showed in the present study that the
method was reliable for predictive screening of six moderate to strong contact
allergens (SI = 12.8 - 39.9) (Figure 11). This was in agreement with previously
published results based on the LLNA (86, 91, 186-187, 190, 192, 194), which
tested chemicals classified as moderate to strong allergens in guinea pigs (8, 33,
187, 192). However, the method failed to discriminate between weak to moderate
contact allergens ( SI = 3.4 - 17.1) and irritants (SI = 5.0 - 10.7). HC and
benzocaine, classified as moderate sensitizers in guinea pig tests (8, 33, 192), gave
low SI-values as also presented in an earlier published report (192). Benzocaine
was not classified as a contact allergen at 25% test concentration (SI < 3).
However, later studies with benzocaine, using DMF as vehicle instead of AOO,
occasionally gave SI-values high enough for its classification as a sensitizer (197).
A number of irritants, without previously known sensitizing properties, were
tested in the present study: chloroform/methanol (2:1) (198), methyl salicylate (96,
188, 199-200), nonanoic acid (157, 201-202), oxalic acid (203), SDS (33) and
Triton X-100 (204). All these gave a clear proliferation in at least one of the
concentrations used and could thus be classified as contact allergens. Comparable
results have been reported with the irritants: nonanoic acid, methyl salicylate and
SDS (81, 142). In contrast, in some other reports, irritants do not induce a marked
proliferative response (95, 165, 186, 192, 194, 205-206). In the case of SDS, this
discrepancy could be due to variations in SDS preparations from different
manufacturers (207). However, 10% SDS from two different suppliers (paper I)
has been tested on eight additional occasions and gave at all times SI-values above
the limit (SI=3) (paper I). The dose-response seen for the irritants tested was also
seen in a study where different concentrations of SDS were tested (142, 208).
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However, the proliferative activity observed after application of Triton X-100 may
be due to allergenicity of ethoxylated non-ionic surfactants (166). Other substances
regarded as non-sensitizers have been reported to induce marked cell proliferation in
the LLNA: mineral oil (195), benzalkonium chloride, salicylic acid (194), copper
chloride (206) and in addition, in later studies, heavy and light mineral oil,
monoolein, squalene, squalane, pristane, Arlacel A, peanut oil, olive oil and
Freund’s complete and incomplete adjuvant (paper II, 149, 209).
Presenting substances tested in LLNA with EC3 values, has been suggested as a
better way of ranking substances according to their proliferation activity, as EC3
values indicate a substance’s relative skin-sensitizing potential (90, 142-143, 149,
205, 210). However, the calculated EC3 for methyl salicylate and nonanoic acid in
paper II, was at about the same level as four of the five allergens compared in Table
6. Thus, the EC3 could not be used to distinguish allergens from the two irritants
tested.
Methyl salicylate has previously been reported to elicit positive results in the
LLNA (81), coincident with our results in paper I and II. These findings are in
contrast to other studies claiming methyl salicylate to be negative in the LLNA (95,
186, 192, 194, 205-206). However, most of these other studies used AOO as
vehicle (95, 204-206). These dissimilarities in results of the proliferation assay for
methyl salicylate have been proposed to be due to the vehicle used, i.e. DMF (95).
Methyl salicylate was tested with the two different vehicles DMF and MEK in the
LLNA, and nearly the same level of proliferation was obtained (Figure 12 and paper
II). It is more interesting to note that the test concentrations used in most of the
studies with negative outcome for methyl salicylate were low (25% or less) (95,
186, 188, 192, 205), which in Figure I in paper II only occasionally gave positive
results. However, in a recently published paper 100 % methyl salicylate was tested
in the LLNA with a negative result (165).
The choice of vehicle could, though, be of interest when the proliferation activity
is studied in the LLNA. In some studies, oxazolone (180) and DNCB (211) have
been tested with various vehicles and different results were obtained (ref).
Benzocaine gave a low SI-value in the study in paper I, probably because of
incomplete absorption due to evaporation of acetone in the vehicle AOO (Table I in
paper I and 197). AOO treatment alone induces highly variable proliferative
responses and AOO is therefore not a suitable vehicle (149, 212), and OO
possesses an inherent capacity to induce high proliferation in the LLNA (149).
Nevertheless, another published report states that AOO is a reasonable first-choice
vehicle even though presenting similar results (212) as in our earlier report (149).
When the vehicle-treated control group values vary on different test occasions this
may result in unspecific changes in SI-values for the test substance. In this study,
variations in the vehicle treated or the untreated control group were seen in the range
of 100-500 dpm per lymph node (Tables I-III in paper I and Tables I-II, paper II).
Some other vehicles, e.g DMF, DMSO or Azone®, are known to increase skin
absorption, which also may influence the result (213).
It has been proposed that adding 10% SDS, an irritant, to all vehicles used could
reduce the background noise sometimes induced by irritation (90). This cannot be
recommended since some allergens may act synergistically with the irritant, as
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shown with t-cinnamic aldehyde (Figure 14b), while others may give an additive
response, as shown with HC (Figure 14a) (paper I). This synergistic effect seems
not to be due to increased absorption (208), though it could be due to the strong
irritating properties of t-cinnamic aldehyde (paper I).
The time-pattern of the effects of 10% SDS (33) on proliferation was tested in
LLNA (paper I) due to the classification of 10% SDS as a sensitizer. It has been
suggested that the proliferative activity seen for irritants could be due to
‘environmental’ antigens or non-antigenic-specific lymphocyte proliferation (89-90)
The proliferation reached a level that could classify SDS as a sensitizer 3 days after
the first application. This fast kinetic profile accords well with proliferative
responses induced by potent allergens (88) and with the time course of Langerhans
cell accumulation in draining lymph nodes after SDS treatment (208). SDS
treatment of the skin in humans also induces a large increase in the amounts of
various inflammatory cytokines and cells, including Langerhans cells in the draining
lymph (214-217).
It can be concluded that the LLNA was reliable for predicting moderate to strong
contact allergens. However, the method failed to discriminate between weak to
moderate contact allergens and irritants.
5.4 Comparison of results from three predictive animal test
methods and patch test in dermatitis patients: the allergenicity
of a preservative [V]
The preservative Euxyl K 400 has two ingredients, methyldibromo glutaronitrile
(MDBGN) (20%) and 2-phenoxyethanol (PE) (80%) (218). MDBGN is considered
to be the principal allergen, whereas PE is a rare sensitizer (219-220). The
preservative, i.e. Euxyl K 400, has given a number of sensitized dermatitis patients
since the introduction on the market and in a German multicenter study carried out
between 1990-1995, MDBGN is number 15 on the toplist when common allergens
from the standard series were tested (10). There are several case reports and
multicenter studies on contact allergy to Euxyl K 400 and its two ingredients in the
literature (218, 221-230), and the use of MDBGN in products is monitored in
Sweden (231-232) (V). The attempts to define the allergenicity of Euxyl K 400
experimentally have earlier given conflicting results. Seven human repeat insult
patch tests (HRIPT) and eleven studies using the guinea pig maximization test
(GPMT) with MDBGN were reported negative (233). Both ingredients in one
GPMT study (234) and MDBGN in a modified Freund’s complete adjuvant test
(235) gave some sensitization reactions. In two optimization tests performed, 1/20
and 13/20 of the guinea pigs reacted to PE given intradermally, but not to topical
challenge (0/20) (236).
An investigation of the allergenicity of MDBGN and Euxyl K 400  using three
different animal models for predictive testing: the LLNA in mice, and the GPMT
and the CCET using a dose-response protocol in guinea pigs. The results were
compared with the frequency and causes of positive patch test reactions to Euxyl K
400 and MDBGN in patients with work-related contact dermatitis. The choice of the
experimental methods used for the present investigation was based on their different
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induction routes. The GPMT (33) has a combination of one intradermal
administration and one topical application at induction, while the LLNA (92) and the
CCET (40) have multiple topical applications only, three and four times,
respectively. The GPMT and the LLNA are two of the four predictive test methods
recommended in the OECD guidelines (53). However, it is also stated that there
may sometime be circumstances where other predictive test methods may be used
(53).
The patch testing of 1770 patients - referred due to work-related contact dermatitis
- with Euxyl K 400 or MDBGN resulted in 9 with relevant positive reactions (Table
5). The majority had been exposed to soaps, shampoos, cleansing agents, creams
and lotions, i.e. the same type of exposure as in non-occupational cases (218-222,
226-228, 237-238). Two predictive animal test methods, i.e. the CCET with the
application of a multi-dose-response induction protocol and the LLNA confirmed
human data. The fitted dose-response curve obtained of results from the CCET was
non-monotone (section 5.1) for the induction series (Figure 17) and monotone for
the challenge series (Figure 1b in paper V). Single positive reactions were seen at
some challenge concentrations in both the exposed and vehicle treated animals
(Table 2 in paper V), a phenomenon which was further discussed in paper V and
also in section 5.1. This slightly influenced the base level (P0) in the data
assessment (Figure 17 and Figure 1b in paper V). The sensitizing capacity of
MDBGN was presented as EC50, the threshold concentration for sensitization and
the maximal sensitization rate (Table 13). The LLNA classified Euxyl K 400 and
MDBGN diluted in DMF or PE as contact allergens with SI-values above 3 at the
test concentration 5% (Table 4 in paper V and Figure 18). The results with
MDBGN in the two different vehicles, DMF and PE, were similar, indicating that
PE did not have any strong contact allergenic or irritating properties in the LLNA.
Euxyl K 400 can also be classified as sensitizing since it was the product used when
testing 20% MDBGN in PE (Table 4 in paper V and Figure 18). Some positive
reactions to MDBGN were found in the GPMT (Table 12) at the highest test
concentration (1%) in both vehicles, but no statistically significant difference
compared to the controls was found. This result was in agreement with earlier test
results from GPMT studies (233-234).
It is reasonable to believe that the outcome in the GPMT method was due to too
few topical treatments at induction, i.e. that the total dose applied topically was too
low, for this particular test substance. It was probably not due to the topically
applied concentration being too low, since the results from the CCET study gave a
maximal sensitization rate at the induction concentration 10% (Table 2 in paper V
and Figure 17), the same concentration used for the single topical application in the
GPMT (Table 12). The various vehicles used at induction could not explain the
variation in reactivity, since acetone most likely had evaporated at the time of
application. The divergent results from the various animal predictive test methods
indicate that multiple topical applications of MDBGN, as in the CCET method and
in the LLNA, are required to obtain sensitization. The need for repeated topical
applications could be due to MDBGN being extremely labile in biological systems
in the presence of sulfhydrylgroups (239-240), a fact which is further discussed in
paper V. Divergent results when using the GPMT, the CCET and the LLNA have
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also been obtained in an investigation on the allergenic properties of sulphanilic acid
(241). However, in that study the GPMT showed that sulphanilic acid had an
allergen potential, whereas the CCET and the LLNA failed to detect the substance as
a sensitizer. In the present study it also seems likely, as discussed in section 5.1,
that the influence of intradermal and topical exposure on sensitization varies with the
chemical tested.
It can be concluded that the choice of test method could be significant for the
possibility to detect a sensitizer and for these particular substances a predictive test
method with multiple topical applications had to be used.
5.5 Comparison of the animal predictive test methods used
Comparisons between various predictive animal test methods are difficult to
perform, since they have various prerequisites such as, e.g., different sensitization
and challenge procedures, different applications sites, different immunological
enhancement techniques, and also the use of different animal species. There are
several inbred mouse strains available; however, the choice of strain for a test
method could make the assay less sensitive to one or more of the substances under
study. The guinea pigs are outbred, giving a genetic heterogeneity, which can be
viewed as a small model for the individual genetic diversity in humans. However, it
is also possible to have a mix of guinea pigs, which may have a lower susceptibility
to one or more of the substances under study. In addition, the results are presented
differently for the various test methods. One predictive test method presents its
results by including the degree of the ‘positive’ sensitization reactions in the
prediction of the sensitizing potentials, i.e. the LLNA (90), while the other test
methods discussed in this thesis, i.e. the MEST (68), the GPMT (33), the CCET
(40), and the FCAT (36) may present both the degree of the elicitation reaction and
the relative number of sensitized animals. However, a comparison was made of the
five predictive test methods used with all the substances tested in this thesis, and the
results are summarized in table 15. Literature data on patch test results in dermatitis
patients were also included in this table for the tested contact allergens (Table 15).
The degree of sensitization response in each test method was estimated for each test
substance, and the concentrations used were taken into consideration. Table 15
shows that four contact allergens, i.e. oxazolone, K2Cr2O7, MDBGN, and HC, and
one irritant, i.e. oxalic acid, have been tested with at least two predictive test
methods in this thesis.
Oxazolone is a strong experimental contact allergen, which was used as a positive
control in the test methods (Table 15). This substance showed a strong sensitization
in both the LLNA (Table I in paper I and Figure 11) and the MEST (Tables 9 and
Figure 16a). Oxalic acid (203) obtained a ‘negative’ response in the MEST (Table
9). However, in the LLNA this irritant was classified as a sensitizer as well as the
other tested irritants (Table II in paper I and Figure 11), used as ‘negative’ controls
in the methods (Table 15).
The moderate contact allergen K2Cr2O7 (Table 15) gave a higher sensitization rate
with stronger reactions in the three guinea pig test methods (Table 7 and Figure 15a)
than in the MEST (Table 9 and Figure 16b). The FCAT showed the highest
sensitization rate for K2Cr2O7 (Tables 7 and Figure 15a), followed by the GPMT
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and then the CCET. In an earlier experimental study, the GPMT gave also a high
sensitization rate for this substance (8). In the mouse methods a variable degree of
sensitization has been presented. The MEST (68, 70) only showed weak
sensitization responses to K2Cr2O7, but with the LLNA some have obtained a low
response (92, 115, 185, 242), while other have obtained a moderate response (120,
191-192, 205, 243). The optimization test gave a very high sensitization rate with
an intradermal challenge, but only a moderate sensitization with a topical challenge
(236). K2Cr2O7 is included in the standard series used for patch testing in dermatitis
patients (Table 15).
Divergent sensitization results were obtained with the weak contact allergen
MDBGN in the two guinea pig test method tested (Table 15). In the CCET (Table 2
in paper V and Figure 17) MDBGN showed a strong sensitization, while the
sensitization results from the GPMT (Table 12) were not statistically significant.
Similar results were seen in several earlier studies using the GPMT (233-234).
Some weak reactions were observed when using a modified FCAT (235),
however, the test results could be questioned (paper V). The LLNA showed
stronger sensitization to MDBGN than the MEST did, while compared to the guinea
pig test methods, both mice test methods showed a low sensitization (Table 15).
The sensitization result from the LLNA (Table 4 in paper V and Figure 11) was
stronger than the results from the MEST (Table 9), since the sensitization criterion
for the MEST had to be lowered to 5 % to obtain a ‘positive’ response. However,
the interpretation of the result was somewhat difficult when the LLNA was used,
since the results with MDBGN were in the same SI-range as some well-known
irritants, e.g. SDS (paper I-II). However, MDBGN seems to require several topical
applications to obtain a ‘positive’ sensitization. This substance is included in the
standard series used for patch testing in dermatitis patients (Table 15).
The weak contact allergen HC was tested in the three guinea pig test methods and
in both the LLNA and the MEST (Table 15). However, the level of sensitization did
not agree in mice and in guinea pigs. In all three guinea pig test methods HC
showed a stronger sensitization than in the mouse test methods (Table 15). The
strongest response to HC was seen in the CCET (Table 7 and Figure 15b), whereas
in the LLNA, HC was barely classified as a sensitizer (Table I in paper I and Figure
11) and in the MEST, HC obtained a ‘negative’ response (Table 9). In earlier
published studies with HC tested in the GPMT according to the original protocol
(33) the substance was classified as a low to moderate allergen (8). However, in the
MEST, a weak statistically significant response has been shown (67, 81). HC has
also been classified by others as a weak sensitizer in the LLNA (191-192). The
discrepancies could be due to differences in exposure concentrations. This
substance is included in the fragrance mix in the standard series used for patch
testing in dermatitis patients (Table 15).
The predictive animal test methods that correctly could predict the sensitizing
potential for the weak and moderate contact allergens tested were the CCET and the
FCAT (Table 15).
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5.6 Concluding remarks and recommendations
Results from the animal predictive test methods are widely used in risk assessment
of chemicals at advisory and regulatory institutes and authorities. Chemical and
pharmaceutical production companies are very dependent on a proper risk
assessment before their products are released on the market. To perform a proper
risk assessment of a test substance (section 1.3), several different investigations
must be done and one of these is a sensitization study of a test substance with a
predictive animal test method. This study is supposed to give an answer as to
whether the substance has an inherent potential to sensitize. Therefore, it is
important that the test method gives a reliable test result for the prospected use of
that substance. Sometimes it is also interesting to know how strong the sensitizing
potential is for a particular substance compared with other substances, that could be
used for the same purpose in a product. However, it is also always of great
importance to know the extent of exposure of humans. If the exposure of humans to
one substance has become too extensive, and an increasing sensitization frequency
to that substance has been noted at patch testing, another substance could take its
place in a product, if a lower degree of sensitization has been shown for that second
substance.
Even though LLNA and MEST have some advantages compared to the guinea pig
test methods concerning speed, labor-intensiveness and cost, and the use of an
objective end point, the methods are not at present capable of replacing the
predictive guinea pig test methods. The LLNA is useful for detection of moderate to
strong contact allergens (SI = 12.8 - 39.9), but it does not adequately discriminate
between weak to moderate contact allergens (SI = 3.4 - 17.1) and irritants (SI = 5.0
- 10.7). The LLNA could falsely classify substances with exclusively irritating
properties to be allergens or, alternatively, overestimate the allergenicity of
chemicals with both allergenic and irritating properties. The MEST is judged to be
less capable of detecting potential contact allergens than the LLNA, but on the other
hand no false ‘positive’ reactivity with the irritant tested was seen. Both the LLNA
and MEST gave lower sensitization responses with the weak and moderate contact
allergens tested than the guinea pig test methods did. Neither the LLNA nor the
MEST could be recommended as the only predictive test method for contact
allergens. However, they could be used for screening of sensitizers. If a SI<12 is
obtained for a substance using the LLNA or if no statistical significant dose-
response relationship is obtained using a multi-dose-response induction protocol on
the modified MEST, a retest with a guinea pig test is recommended. It is preferable
is to use a multi-dose-response induction protocol in the CCET or the FCAT, since
they gave reliable results with the substances tested and are easy to perform. It
should also be noted that one substantial benefit of using predictive guinea pig test
methods is the possibility to study cross-reactivity (244). This cannot be done in the
LLNA, due to its design. It is possible, however, to perform cross- reactivity
studies in the MEST, but only with one test substance on each mouse.
It is recommended that the investigator, whose aim it is to study the sensitizing
potential of a substance should choose the induction procedure that is most relevant
for the prospected use. The investigator should be aware of the possibility of using
other available standardized predictive animal test methods. A test method with a
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particular induction route may be more suitable for testing a substance than one of
the recommended methods. The investigator should also be observant of the
varying ability of the predictive test methods to detect the sensitizing potential of a
substance. Dose-response designs of predictive test methods increase the amount of
information obtained from each sensitization study, but are not generally included in
all animal test methods today. The investigator should consider including dose-
response designs in the protocols used when the sensitizing potential of a substance
is investigated, since there is a risk of missing a sensitization due to a too low or a
too high induction (or challenge) concentration if only one induction (or challenge)
concentration is used. Calculation of EC50 values improves the possibility of proper
ranking of contact allergens and augments the information used in risk assessment.
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6. Conclusions
• A variety of predictive test methods for the investigation of potential contact
allergens are available.
 
• Dose-response designs of predictive test methods increase the amount of
information obtained from each sensitization study and should be considered for
inclusion in the protocols when the sensitizing potential of a substance is
investigated.
 
• Application of a multi-dose-response induction protocol to guinea pig test
methods with only one induction route, i.e., the CCET and the FCAT, makes
them a good choice of methods for predictive testing. However, for a guinea pig
test method with two induction routes, i.e. the GPMT, the topical doses at
induction interacted with the logistic model.
 
• It is possible to use the multi-dose-response induction protocol applied on the
modified MEST for screening of sensitizers. However, if no statistically
significant dose-response relationship is obtained, a retest with a guinea pig test
method should be performed.
 
• It is possible to use the LLNA for screening of sensitizers. However, if a
stimulation index (SI) < 12 is obtained, a retest with a guinea pig test method
should be performed.
 
• Guinea pig test methods gave in general a higher sensitization rate than the
mouse test methods for the substances tested.
 
• The guinea pig test method giving the highest sensitization rate varied with the
particular substance tested in this thesis.
 
• The MEST was judged to be less capable of detecting potential contact allergens
than the LLNA, but on the other hand no false ‘positive’ reactivity with the
irritant tested was seen.
 
• The choice of test method could be significant for the possibility to detect a
sensitizer, since the predictive test methods have various capacities to detect the
sensitizing potential of a substance. The test method should have the induction
procedure that is most relevant for the prospected use of the substance being
tested.
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7. Summary
Wahlkvist H. Predictive testing for contact allergy: Comparison of some guinea pig
and mouse protocols including dose-response designs. Arbete och Hälsa 1999: 21.
Contact allergy (delayed hypersensitivity) may develop as a result of skin exposure
to contact allergens (haptens) and can lead to allergic contact dermatitis. The
purpose of this study was to evaluate some predictive animal test methods for
contact allergens. It was done with the aim that the test methods giving the clinically
most relevant results should be used in risk assessment of chemicals and in
research.
A slightly modified multi-dose-response induction protocol was evaluated with
two model contact allergens when applied to three guinea pig predictive test
methods. The protocol was easily applied to the cumulative contact enhancement
test (CCET) and the Freund’s complete adjuvant test (FCAT), which have only one
induction route. However, for the guinea pig maximization test (GPMT) with two
induction routes, the topical doses at induction interacted with the logistic model.
The protocol would benefit from further development and some modifications are
suggested. Calculations of the estimated concentration sensitizing 50 % of the
animals (EC50) improves the possibility for proper ranking of contact allergens and
augments the information used in risk assessment. The calculated EC50-values for
the model allergens were: 0.00045 % in the FCAT, 0.0025 % in the GPMT and
0.0042 % in the CCET for potassium dichromate (K2Cr2O7), and 0.068 % in the
GPMT, 0.89 % in the FCAT and 1.8 % in the CCET for hydroxycitronellal (HC).
A multi-dose-response induction protocol was applied on a modified mouse ear
swelling test (MEST) and evaluated with four contact allergens and one irritant.
This protocol could detect the moderate to strong contact allergens as sensitizers,
but not one (HC) of the two weak contact allergens. The irritant (negative control)
gave a ‘negative’ response. The EC50-values calculated for the three detected
allergens were 0.002 % for oxazolone, 0.03 % for K2Cr2O7 and 0.7 % for
methyldibromo glutaronitrile (MDBGN).
The murine local lymph node assay (LLNA) is a predictive test method, but its
ability to discriminate between allergens and irritants has been questioned. Eight
contact allergens and six irritants were investigated in the evaluation of the LLNA.
The moderate to strong allergens gave clearly ‘positive’ results (stimulation index
(SI) = 12.8 – 39.9), but one weak allergen (benzocaine) was not classified as a
sensitizer (SI<3). The irritants tested, i.e. chloroform/methanol, methylsalicylate,
nonanoic acid, oxalic acid, sodium dodecyl sulfate (SDS), Triton X-100, however,
gave also ‘positive’ results (SI = 5.0 – 10.7), not distinguishable from the results
with weak and moderate contact allergens (SI = 3.4 – 17.1). The addition of 10%
SDS could not be used to reduce the induced proliferation due to irritation from the
test chemicals, nor could an alternative choice of vehicle.
The allergenicity of a preservative, i.e. Euxyl K 400, and one of its ingredients,
MDBGN, was investigated in three different animal predictive test methods, and
patch testing in dermatitis patients was performed for comparison. The CCET using
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a multi-dose-response induction protocol (EC50 = 1.9 % for MDBGN) and the
LLNA (SI = 7.4 - 7.9 for MDBGN and 8.4 - 12.0 for Euxyl K 400) confirmed the
sensitization potential of the substance based on dermatitis patients patch test results
(total frequency varied between 0.9 - 1.8 %). However, the results from the GPMT
were not statistically significant.
In conclusion, even though the LLNA and the MEST have some advantages
compared to the guinea pig test methods concerning speed, labor-intensiveness and
cost, and the use of an objective end point, the methods are at present not capable of
replacing the predictive guinea pig test methods. Both the LLNA and MEST gave a
lower sensitization rate with the weak and moderate contact allergens tested than the
guinea pig test methods did. The MEST is judged to be less capable of detecting
potential contact allergens than the LLNA, but on the other hand no false ‘positive’
reactivity with the irritant tested was seen. Dose-response designs of predictive test
methods increase the amount of information obtained from each sensitization study
and should be considered for inclusion in the protocols used when the sensitizing
potential of a substance is investigated.
Investigators are advised to select the predictive test method with the induction
procedure that is most relevant for the prospected use of the substance being tested.
A test method with a particular induction route may be more suitable for testing a
substance than one of the recommended methods, so there is also a possibility to
use other available standardized predictive animal test methods. However, that
predictive test methods have a varying capacity to detect the sensitizing potential of a
substance is evident.
Key words: contact allergens, contact allergy, cumulative contact enhancement test,
dose-response, evaluation, Freund’s complete adjuvant test, guinea pig
maximization test, local lymph node assay, mouse ear swelling test, patch test,
predictive testing, statistical analysis.
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8. Sammanfattning (summary in Swedish)
Wahlkvist H. Predictive testing for contact allergy: Comparison of some guinea pig
and mouse protocols including dose-response designs. Arbete och Hälsa 1999: 21.
Kontaktallergi (fördröjd överkänslighet) kan utvecklas vid hudexponering för
kontaktallergen (hapten) och kan orsaka allergiskt kontakteksem. Syftet med studien
var att utvärdera några djurmetoder för prediktiv testning av kontaktallergen.
Tyngdpunkt lades vid att den testmetod som ger de kliniskt mest relevanta resultaten
bör användas vid riskvärdering av kemikalier och inom forskning.
Ett delvis modifierat protokoll för induktion med multi-dos-respons utvärderades
med två modellkontaktallergen som applicerades på tre prediktiva testmetoder på
marsvin. Protokollet kunde utan svårigheter tillämpas på ”the cumulative contact
enhancement test” (CCET) och ”the Freund´s complete adjuvant test” (FCAT), vilka
har endast en exponeringsväg vid induktion. Men i ”the guinea pig mazimization
test” (GPMT) som använder två exponeringsvägar, interagerade den topikala dosen
i induktionen med den logistiska modellen. Protokollet skulle kunna förbättras
ytterligare genom några modifieringar som föreslogs. Beräkning av den
koncentration som sensibiliserar 50 % av djuren (EC50) förbättrar möjligheten att
rangordna kontaktallergen och ökar mängden information för riskvärdering. De
beräknade EC50-värdena för modellallergenen blev 0,00045 % med FCAT, 0,0025
% med GPMT och 0,0042 % med CCET för kaliumdikromat (K2Cr2O7), och 0,068
% med GPMT, 0,89 % med FCAT och 1,8 % med CCET för hydroxycitronellal
(HC).
Ett induktionsprotokoll för multi-dos-respons applicerades på ett modifierat
”mouse ear swelling test” (MEST) och utvärderades med fyra kontaktallergen och
en irritant. Protokollet kunde identifiera de testade moderata till starka
kontaktallergenen som sensibiliserande, men inte det ena (HC) av två svaga
kontaktallergen. Irritanten (negativ kontroll) gav ett ’negativt’ svar. De beräknade
EC50-värdena för de tre ämnen som identifierades som allergen var 0,002 % för
oxazolon, 0,03 % för K2Cr2O7 och 0,7 % för metyldibromoglutaronitril
(MDBGN).
”The murine local lymph node assay” (LLNA) är en prediktiv testmetod, vars
förmåga att skilja mellan allergen och irritanter har ifrågasatts. Åtta kontaktallergen
och sex irritanter användes i utvärderingen av LLNA. De moderata till starka
allergenen gav tydliga ’positiva’ resultat (stimuleringsindex (SI) = 12,8 – 39,9),
men ett svagt allergen (bensokain) blev inte klassificerat som sensibiliserande
(SI<3). Irritanterna som testades, kloroform/metanol, metylsalicylat, nonansyra,
oxalsyra, natriumdodecylsulfat (SDS), Triton X-100, gav också ’positivt’ resultat
(SI = 5,0 – 10,7), som inte kunde särskiljas från resultaten med svaga och moderata
allergen (SI = 3,4 – 17,1). Tillägg av 10 % SDS minskade inte proliferationen som
orsakats av irritation från testkemikalierna, inte heller användandet av annan vehikel
gjorde detta.
Den allergiframkallande potentialen hos ett konserveringsmedel, Euxyl K 400 och
en av dess ingredienser, MDBGN, undersöktes med tre olika prediktiva testmetoder
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på djur, och resultaten jämfördes med resultat från lapptestning på eksempatienter.
CCET med ett induktionsprotokoll för multi-dos-respons (EC50 = 1,9 % för
MDBGN) och LLNA (SI =7,4 – 7,9 för MDBGN och 8,4 – 12,0 för Euxyl K 400)
bekräftade substansernas allergiframkallande förmåga, liksom lapptestresultat hos
eksempatienter giorde (total frekvens positiv varierade mellan 0,9 % och 1,8 %).
Resultaten från GPMT var inte statistiskt signifikanta.
Slutsatsen är att, även om LLNA och MEST har några fördelar jämfört med
marsvinsmetoderna beträffande tidsåtgång, arbetsinsats och kostnad, och
användande av objektiv mätmetod, kan metoderna inte ännu ersätta
marsvinsmetoderna. Både LLNA och MEST gav lägre sensibiliseringsfrekvens med
de testade svaga och moderata kontaktallergenen än marsvinsmetoderna. MEST
bedöms ha sämre förmåga att upptäcka potentiella kontaktallergen än LLNA, men å
andra sidan iakttogs inte någon falsk positiv reaktivitet med den testade irritanten.
Dos-responsdesign hos prediktiva testmetoder ökar mängden information från varje
sensibiliseringsstudie och bör övervägas att inkluderas i protokoll för undersökning
av den sensibiliserande potentialen hos substanser.
Rekommendationen blir att en prediktiv testmetod med en induktionsväg som är
mest relevant för den framtida användningen av den testade substansen bör
användas. En testmetod med en viss induktionsväg kan vara mer lämpad för
testning av substansen än någon av de rekommenderade metoderna, så det är också
möjligt att använda andra tillgängliga standardiserade prediktiva testmetoder utförda
på djur. Men, det är uppenbart att de prediktiva testmetoderna har olika förmåga att
identifiera den sensibiliserande potentialen hos substanser.
Nyckelord: cumulative contact enhancement test, dos-respons, utvärdering,
Freund’s complete adjuvant test, guinea pig maximization test, kontaktallergen,
kontaktallergi, lapptestning, local lymph node assay, mouse ear swelling test,
prediktiv testning, statistisk analys
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